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Pain and itch are two distinct yet related sensations. Here we present a series of experiments 
elucidating mechanisms of pain and itch in central and peripheral nervous systems. Coding of itch 
versus pain has been hotly debated for decades. However, the current coding theories (labeled 
line, intensity and selectivity theory) cannot accommodate all experimental observations. We 
identified a subset of spinal interneurons, labeled by gastrin releasing peptide (Grp), that receive 
direct synaptic input from both pain and itch primary sensory neurons. When activated, these 
Grp+ neurons generated rarely-seen simultaneous robust pain and itch responses that were 
intensity-dependent. Accordingly, we propose a “leaky gate” model, in which Grp+ neurons 
transmit both itch signals and weak pain signals (ensuring pain sensitivity) through the “gate”, but 
recruit endogenous opioid systems to close the “gate” upon strong painful stimuli to prevent 
overwhelming pain. Consistent with our model, loss of these Grp+ neurons increased pain 
responses while itch was decreased. Our new model incorporates currently underappreciated non-
monotonic coding in the spinal cord and better explains observations in human psychophysical 
studies. We also explored peripheral mechanisms mediating protease induced itch. Various 
endogenous and exogenous proteases can trigger intense itch sensation, presumably via Protease-
Activated-Receptor, PAR2. Here we demonstrate that in contrary to the current hypothesis, 
cysteine proteases including cathepsin S, activate dorsal root ganglion neurons and elicit 
scratching through Mas-related G protein coupled receptor, MrgprC11, but not PAR2. In contrast 
to its activation of conventional protease-activated receptors, cathepsin S-mediated activation of 
MrgprC11 did not involve the generation of a tethered ligand. This expansion of our 
understanding by which proteases interact with G-protein-coupled receptors (GPCRs) redefines 
the concept of what constitutes a protease-activated receptor. The findings also implicate 
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proteases as endogenous ligands to members of this orphan receptor family while providing new 
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CHAPTER 1: INTRODUCTION 
         Itch, also known as pruritus, is defined as an “unpleasant sensation that elicits the desire or 
reflex to scratch”(Ikoma et al., 2006) and can be distinguished as acute and chronic forms with 
the latter lasting more than six weeks(Ständer et al., 2007). Itch can be caused by various stimuli 
including those that are mechanical, electrical and chemical, with exogenous and endogenous 
chemical stimuli ranging from amines, proteases, neuropeptides to inflammation mediators and 
certain drugs (see Table 1.1)(Akiyama and Carstens, 2013). Acute itch, such as that caused by a 
mosquito bite, is commonly experienced in daily life and has a protective role as to remove 
irritants and avoid future insults. Histamine mediated itch is well studied, while non-
histaminergic itch attracts more and more attention in recent year. Histamine and non-histamine 
itch seem to activate largely non-overlap projection neurons in the spinal cord(Akiyama et al., 
2009; Davidson et al., 2007) and non-histaminergic projection neurons were found to terminate in 
more thalamic nuclei(Davidson et al., 2012). The mechanical pain generated by scratching can 
usually suppress acute itch, however chronic itch conditions commonly accompanied with co-
morbidities, such as depression and sleep disorders, can be debilitating and remain unmet clinical 
needs. Chronic itch conditions are generally divided into four categories: dermatological, 
systemic, neurological and psychogenic. Dermatological itch comes from skin conditions such as 
atopic dermatitis, psoriasis and urticaria. Systemic itch can be caused by pathology of other 
organs, for example liver cholestasis and kidney dialysis. Neurological itch is caused by direct 
damage to the nervous system either peripherally or centrally. Finally, psychogenic itch is 
associated with psychological and psychiatric disorders. This chapter is modified from previous 
publication(Sun and Dong, 2016). 
         Pain and itch are two distinct yet related sensations. Itch sensation is initiated in the skin 
while pain sensation in muscles and internal organs in addition to skin. Both pain and itch are 
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detected by peripheral afferents of similar small diameter primary sensory neurons, with cell 
bodies located in dorsal root ganglia (DRG) and trigeminal ganglia. These sensory signals are 
then carried by small unmyelinated C fibers and lightly myelinated Aδ fibers with slow 
conduction velocities to the spinal dorsal horn and further to the brain. Yet pain and itch trigger 
distinct behavioral responses. Pain generates a withdrawal response to avoid tissue damage, while 
itch elicits scratching to remove irritants. Pain can suppress itch, which is demonstrated when the 
mechanical pain generated by scratching relieves the itchy feeling (Davidson et al., 2009). Itch, 
however, can rarely suppress pain.  
 
Figure 1.1 Diagram of pain and itch pathways in DRG and the spinal cord 
Pain and itch signals from periphery transmit to DRG, spinal cord and then further to the brain. 
Representative subsets of DRG neurons: TrpV1 and MrgD marks subsets of peptidergic and non-
peptidergic nociceptors respectively; H1R, MrgA3 and HTR7 marks pruriceptive subsets 
responsive to histamine, chloroquine and serotonin respectively. Representative subsets of spinal 
cord neurons: NK1 marks projection neurons sending output to higher brain areas; Grp and SST 
marks excitatory interneuron populations involved in pain and itch transmission; B5I and NPY 
marks inhibitory interneuron populations responsible for inhibition of chemical and mechanical 




DRG neurons have pseudo-unipolar morphologies, sending output to spinal cord. In 
addition to the classic distinction of peptidergic and non-peptidergic nociceptors, for example as 
labeled by TrpV1 and MrgD(Cavanaugh et al., 2009; Mishra et al., 2011), respectively in Figure 
1.1, new markers for pruriceptive subsets have recently been established. Multiple Mas-related G 
protein coupled receptors (Mrgs) were found to be itch receptors, including MrgA3 responsive to 
chloroquine(Liu, 2009), MrgC11 to BAM and SLIGRL(Liu, 2009, 2011) and subset of MrgD to 
β-alanine(Liu et al., 2012). Unlike DRG neurons, which all serve output functions, only a small 
subset of dorsal horn neurons transmit signals further to the brain(Spike et al., 2003), as marked 
by NK1(Todd et al., 1998) in Figure 1.1. The remaining majority are interneurons forming 
interlacing spinal circuitries. Interneurons in superficial lamina have been carefully characterized 
based on their morphologies and firing patterns(Grudt and Perl, 2002), yet their functions remain 
largely elusive. In the past few years, several genetically labeled populations(Bourane et al., 
2015a; Duan et al., 2014; Kardon et al., 2014), including SST, B5I and NPY as shown in Figure 
1.1, have been defined with functions relating to pain and itch, promoting the functional 
dissection of complex spinal cord circuitries. 
On the cellular level, neurons responsive to itchy stimuli in both DRG and the spinal cord 
can also be activated by pain (Akiyama et al., 2009; Davidson et al., 2007; Jansen and Giesler, 
2015; Liu et al., 2009; Schmelz et al., 2003), begging the question how these two sensations are 
distinguished (Figure 1.1). Indeed, itch used to be regarded as a sub-modality of pain because of 
their similarities. One related theory is called intensity theory, stating that weak and strong 
activation of the same group of neurons generates itch and pain sensations respectively(Von frey, 
1922; Lewis et al., 1927; Patel and Dong, 2010). Another competing theory is called labeled line 
theory, which, in contrast, proposes mutually exclusive populations for the detection of itch and 
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pain(Norrsell et al., 1999). It is clear now that itch is a distinct sensation from pain. Loss of the 
gastrin releasing peptide receptor (GRPR) population in the spinal cord resulted in a profound 
defect of itch behaviors, but pain responses remained intact unequivocally demonstrating the 
existence of separable itch and pain pathways(Sun et al., 2009). However itch neurons are almost 
exclusively poly-modal. They respond to painful stimuli such as capsaicin or mustard oil in 
addition to itchy stimuli(Liu et al., 2009; Schmelz et al., 2003; Wilson et al., 2011). The coding 
puzzle of itch and pain is better explained by selectivity theory. When the itch population is 
selectively activated, an itchy sensation is generated, regardless of the stimuli. In contrast, when 
an algogen activates a larger population, including both pain and itch sensing neurons strong 
enough, itch is occluded by inhibition from pain neurons, just as scratching induced pain inhibits 
itch and therefore only pain sensation is perceived. Although being two separate sensations, itch 
and pain share common downstream pathways, such as Trp (transient receptor potential) channels. 
 
Table 1.1 Pruritogens and related itch transduction mechanisms 
























Histamine H1R, H4R(Bell et 
al., 2004; Dunford 
et al., 2007) 
TrpV1(Imamachi 
et al., 2009) 
PLCβ3(Han et al., 
2006; Imamachi et al., 
2009), IP3(Nicolson et 
al., 2002),Ca2+(Kim et 
al., 2004; Thurmond et 
al., 
2008),PLA2/LO(Kim 
et al., 2004) 




Gβγ(Wilson et al., 
2011) 




PLC(Wilson et al., 
2011) 
Cathepsin S MrgprC11(Reddy 
et al., 2015) 
  
Tryptase PAR2, 




et al., 1999), 5-





al., 2009), AC, 
Gβγ(Morita et al., 
2015) 
12(S)-HPETE LTB4 receptor 

















HT2(Kim et al., 
2008a) 




PKC, AC(Liang et al., 
2010) 
Cathepsin E ETa(Andoh et al., 
2012) 
  
Bradykinin B2R(Bandell et 
al., 2004; Wang et 
al., 2008) 
TrpV1(Bautista et 
al., 2006; Kim et 
al., 2004), 
TrpA1(Bandell et 
al., 2004; Bautista 
et al., 2006; Wang 
et al., 2008) 
PLA2/LO(Kim et al., 
2004), PLC(Bautista et 
al., 2013) 
Substance P NK1R(Andoh et 
al., 1998) 
 NO(Andoh and 
Kuraishi, 2003), 
LTB4(Andoh et al., 
2001) 
Bile acids TGR5(Alemi et 
al., 2013) 
TrpA1(Lieu et al., 
2014) 






et al., 2004) 
LTB4 LTB4 receptor 




et al., 2013) 
RO(Fernandes et al., 
2013) 















PLC(Wilson et al., 
2013) 
IL31 IL31RA(Cevikbas 
et al., 2014), 
OSMR(Cevikbas 
et al., 2014; 




et al., 2014) 
ERK(Cevikbas et al., 
2014) 
IL13  TrpA1(Oh et al., 
2013) 
 
Imiquimod TLR7?(Liu et al., 
2010) 
 K2P, Kv1.1, 
Kv1.2(Lee et al., 2012) 
LPS (no direct 
itch) 
TLR4(Min et al., 
2014) 
  
Oxidants  TrpA1(Andersson 
et al., 2008; Liu 
and Ji, 2012) 
 
Abbreviation: RO, reactive oxygen.  
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CHAPTER 2: LEAKY GATE MODEL: INTENSITY-DEPENDENT CODING OF PAIN AND 
ITCH IN THE SPINAL CORD 
Introduction  
Pain and itch trigger distinct behaviors, yet itch responsive neurons in both DRG and 
spinal cord also respond to painful signals (Akiyama et al., 2009; Davidson et al., 2007; Liu et al., 
2009; Schmelz et al., 2003), begging the question how these two sensations are distinguished. 
Debates about pain and itch coding have been on-going for decades. The intensity theory (Figure 
2.1A) claims that poly-modal neurons can be stimulated strongly or weakly to generate pain or 
itch sensations respectively(Von frey, 1922; Lewis et al., 1927). However, weaker painful stimuli 
or stronger itchy stimuli fail to turn into a different sensation, as predicted by the intensity theory, 
rendering it untenable(Handwerker et al., 1991; Ochoa and Torebjörk, 1989; Tuckett, 1982). The 
labeled line theory (Figure 2.1B) argues that different senses are coded by mutually exclusive 
populations(Norrsell et al., 1999; Schmelz et al., 1997), but cannot explain the existence of poly-
modal neurons. A modified labeled line theory, termed selectivity theory (Figure 2.1C) 
(Handwerker, 1992; McMahon and Koltzenburg, 1992), suggests that itchy stimuli specifically 
activate itch-selective neurons to generate itch sensation, while painful stimuli activate both itch-
selective neurons and a larger nociceptive population whose activation inhibits itch to produce 
only pain sensation.  
Recent studies largely support selectivity theory(Bourane et al., 2015b; Han et al., 2013; 
Kardon et al., 2014; Mishra and Hoon, 2013; Sun et al., 2009). In DRG, Han et al. confirmed the 
existence of “itch-selective” neurons by showing that the activation of the MrgprA3+ primary 
sensory neurons generated itch but not pain responses, while its ablation impaired itch and spared 
pain(Han et al., 2013). Further along this same labeled line, the “itch-selective” neurons in the 
spinal cord are proposed to be the gastrin releasing peptide receptor (GRPR) positive population. 
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The loss of the GRPR+ neurons abolished most itch responses but spared pain(Sun et al., 2009). 
In addition, brain natriuretic peptide (BNP) is suggested to be the itch-specific neurotransmitter, 
signaling between itch-selective cells in DRG and itch-selective cells in the spinal cord(Mishra 
and Hoon, 2013). However, in human psychophysical studies, most chemical-induced itch 
sensations are accompanied by weaker nociceptive sensations (burning, pricking, stinging etc.) 
(LaMotte et al., 2014). These mixed sensations raise questions about the “selectivity” of itch 
pathways. 
 
Figure 2.1 Diagrams of pain and itch coding theories. 
Diagrams showing (A) intensity theory, (B) labeled line theory and (C) selectivity theory of pain 
and itch coding.   
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Although we cannot deny the beauty of simplicity, the anatomical structure of the spinal 
cord dorsal horn seems to suggest a more complicated and integrative organization of sensory 
circuits than labeled lines. Unlike pseudo-unipolar DRG neurons, which all serve output functions, 
only a small subset of superficial dorsal horn neurons transmit signals further to the brain(Spike 
et al., 2003). The remaining majority are interneurons forming interlacing local circuitries. 
Lamina I neurons can be categorized as fusiform, pyramidal, multipolar and etc. according to 
morphology, with the first two categories representing nociceptive and thermoreceptive neurons 
respectively(Han et al., 1998). Lamina II neurons can be morphologically sorted into islet, central, 
radial, vertical and etc. types(Grudt and Perl, 2002). Largely, the functions of these local 
circuitries remain unknown. Here we attempted to reveal the functions of dorsal horn circuits as 
they related to pain and itch.  Secondary neurons are the first step in the spinal circuitry, receiving 
direct synaptic input from DRG neurons. We identified a subset of secondary neurons, positive 
for Grp, that receive direct synaptic inputs from both pain and itch primary sensory neurons. 
Surprisingly, the activation of the Grp+ neurons generated both pain and itch responses with the 
pain coding being intensity dependent. These data led us to propose a “leaky gate” model which 
provides a refined theory for pain and itch coding in the spinal cord. 
 
Methods 
Mouse lines  
GrpCre and GrpEGFP mouse lines were acquired from MMRRC. MrgprA3Cre mouse line 
was previously generated by our group. ROSA26LSL-tdTomato, ROSA26LSL-ChR2, ROSA26LSL-DTR, 
ROSA26LSL-TrpV1, vGlut2Cre, GAD1EGFP and TrpV1-/- mouse lines were acquired from the Jackson 





Adult mice were anesthetized with pentobarbital and perfused with 20 ml 0.1 M PBS (pH 
7.4, 4 °C) followed with 25 ml of fixative (4% formaldehyde (vol/vol) and 14% sat. picric acid 
(vol/vol) in PBS, 4 °C). Spinal cord and DRG were dissected from the perfused mice. DRG was 
post-fixed in fixative at 4 °C for 30 min, and spinal cord were fixed for 1 h. Tissues were 
cryoprotected in 30% sucrose (wt/vol) for more than 12 h and were sectioned with a cryostat. The 
sections on slides were dried at 37 °C for 40 min, and fixed with 4% paraformaldehyde at room 
temperature for 10 min. The slides were pre-incubated in blocking solution (10% normal goat 
serum (vol/vol), 0.2% Triton X-100 (vol/vol) in PBS, pH 7.4) for 1 or 2 h at room temperature, 
then incubated overnight at 4 °C with primary antibodies. Secondary antibody incubation was 
performed at room temperature for 2 h.  
For primary antibodies, we used rabbit α-CGRP (T-4239, Peninsula, 1:1,000), rabbit α-
NF200 (AB1982, Chemicon, 1:1,000), rabbit α-PKCγ (sc-211, Santa Cruz Biotechnology, 
1:1,000), rabbit α-GFP (A-11122, Molecular Probes, 1:1,000), mouse α-Neuronal nuclei 
(MAB377, Chemicon, 1:200), mouse α-PSD95 (K28/43, NeuroMab, 1:500), rabbit α-PSD95 
(EP1183Y, Millipore, 1:500), guinea pig α-TrpV1 (AB5566, Millipore, 1:200), rabbit α-
MrgprC11 (made by our lab, 1:200) and mouse α-Enkephalin (NOC1, Millipore, 1:100). For 
secondary antibodies, we used goat α-rabbit (A11008, Alexa 488 conjugated; A11011, Alexa 568 
conjugated; A21245, Alexa 647 conjugated, Thermo Fisher), goat α-mouse (A11001. Alexa 488 
conjugated; A11004, Alexa 568 conjugated; A21245, Alexa 647 conjugated, Thermo Fisher) and 
goat α-guinea pig (A11075, Alexa 568 conjugated). All secondary antibodies were diluted 1:500 
in blocking solution. To detect IB4 binding, sections were incubated with Griffonia simplicifolia 





To prepare spinal cord slices, 4 to 6 week-old mice were deeply anesthetized with 2% 
isoflurane (Abbott Laboratories, North Chicago, IL, USA). Spinal cord with dorsal root or DRG 
was rapidly removed and placed in ice-cold, low-sodium Krebs solution which contained: 95mM 
NaCl, 2.5mM KCl, 26mM NaHCO3, 1.25mM NaH2PO4-H2O, 6mM MgCl2, 1.5mM CaCl2, 
25mM glucose, 50mM sucrose, 1mM kynurenic acid bubbled with 95% O2/5% CO2. Sagittal 
spinal cord slices (400µm) with dorsal roots or DRG attached were cut by a Vibratome (VT1200, 
Leica Biosystems, Buffalo Grove, IL, USA) and transferred to low-sodium Krebs solution 
without kynurenic acid for recovery at 34°C for 45 minutes and then at room temperature for an 
additional 1 hour before being used for recordings.  
For electrophysiology recording, slices were stabilized with a nylon harp and submerged 
in a low-volume recording chamber (SD Instruments, San Diego, CA, USA), which was perfused 
with Krebs solution (125mM NaCl, 2.5mM KCl, 26mM NaHCO3, 1.25mM NaH2PO4-H2O, 1mM 
MgCl2, 2mM CaCl2, 25mM glucose) at a rate of 5ml/min bubbled with 95% O2/5% CO2. Whole-
cell patch-clamp recording of Grp+ neuron was carried out under oblique illumination with an 
Olympus fixed-stage microscope system (BX51, Melville, NY, USA). Using a puller (P1000, 
Sutter, Novato, CA, USA), we fabricated thin-walled glass pipettes (World Precision Instruments, 
Sarasota, FL, USA) that had a resistance of 3-6 MΩ and were filled with internal solution 
(120mM K-gluconate, 20mM KCl, 2mM MgCl2, 0.5mM EGTA, 2mM Na2-ATP, 0.5mM Na2-
GTP, and 20mM HEPES). The cells were voltage clamped at –70 mV. Membrane current signals 
were sampled at 10kHz and low-pass filtered at 2 kHz. We monitored R series and R input and 
discarded cells if either of these values changed by more than 20%. 
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DRGs were collected from mice, which were deeply anesthetized with 2% isoflurane 
(Abbott Laboratories, North Chicago, IL, USA) and put in cold DH10 medium (DMEM/F-12 
with 10% fetal bovine serum and 1% penicillin/streptomycin, Gibco) and treated with enzyme 
solution (5mg/ml dispase and 1mg/ml collagenase Type I in HBSS without Ca2+ and Mg2+, 
Gibco) at 37°C. After trituration and centrifugation, cells were resuspended in DH10 with nerve 
growth factor (50ng/ml, Upstate) and glial cell line-derived neurotrophic factor (25ng/ml, R&D 
Systems), plated on glass coverslips coated with poly-D-lysine (100 µg/ml, Biomedical 
Technologies) and laminin (10µg/ml, Invitrogen), cultured at 37°C, and used after 20–40 hours. 
Whole-cell recording of MrgprA3 positive DRG neurons were performed with Axon 700B 
amplifier and pClamp 10 software (Molecular Devices, Sunnyvale, CA). The thin-walled glass 
pipettes were pulled by a puller (P1000, Sutter, Novato, CA, USA) with the resistance of 2-4 MΩ.  
Dorsal roots stimulation was applied by a suction electrode at 500µA, sufficient to 
activate C-fibers, using a Master-9 Pulse Stimulator and Iso-Flex Stimulus Isolator (AMPI, 
Jerusalem, Israel). For light stimulation mediated by channelrhodopsin, the LED blue light (465 
nm, 300 mW/cm2 ) was elicited by a high power LED illumination system(LEX2-B, Brainvision) 
through the Olympus fixed-stage microscope system (BX51, Melville, NY, USA). The LED 
illumination system was connected to an A/D converter (Digidata 1440, Axon CNS, Molecular 
Devices), and controlled by the pClamp10 software (Axon CNS). For DRG attached spinal cord 
slice Grp neurons recording, drugs were directly puffed on the DRG tissue using the DVD-8VC 
superfusion application system (ALA Scientific Instruments, Farmingdale, NY, USA). To 
differentiate monosynaptic and polysynaptic connections, 20 C-fiber-strength electrical 
stimulation or light stimulation at 1Hz were delivered, neurons with no failure in EPSCs were 
monosynaptically connected according to established criteria(Nakatsuka et al., 2000).  
Biocytin Labeling  
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After 20 min in the whole-cell patch-clamp configuration, the biocytin-filled (0.5%) 
electrodes were withdrawn from the targeted neuron, and the slices were immersed in 4% 
paraformaldehyde for 15 min. Spinal slices were then washed with PBS (3 X 20 min) and 
incubated with Alexa-488 conjugated streptavidin (1:200, Life technologies) at 4°C overnight. 
After washing with PBS (3 X 20 min), the fluorescent signals of the spinal cord sections were 
collected as z-series images using a confocal microscope. 
Rabies viral tracing 
Mice were anesthetized by isoflurane and a laminectomy was performed at the T13-L1 
level. A fine glass capillary was inserted into dorsal spinal cord. AAV helper virus, AAV8-LSL-
TVA-EGFP-B19G (UNC vector core), was first injected (500nl, 50nl/min). AAV1-LSL-
tdTomato virus (Upenn vector core) was similarly injected to visualize Grp+ neurons. EnvA 
pseudotyped rabies glycoprotein deficient GFP rabies virus (Courtesy of Dr. Fan Wang’s group, 
Duke University) was injected in the same spot three weeks later. Animals were perfused 7 days 
after rabies virus injection and processed for immunostaining.  
Behavioral testing 
All behavioral tests were performed with an experimenter blind to genotype. The mice 
were 2–4-month-old males that had been backcrossed to C57Bl/6 mice for at least six generations. 
All experiments were performed using protocols approved by the Animal Care and Use 
Committee of Johns Hopkins University School of Medicine. The day before the behavioral tests, 
all mice were acclimated for at least 30 min to their testing environment. We housed 4-5 mice in 




For ablation experiments, we injected 8-week-old GrpCre; ROSA26LSL-DTR;LSL-tdTomato mice 
and ROSA26LSL-DTR;LSL-tdTomato littermates with diphtheria toxin (intra-peritoneal, 35 µg per kg of 
body weight, Sigma) twice, separated by 72 h. Behavioral experiments were performed 4 weeks 
after the first toxin injection.  
Back injections were performed as previously described(Han et al., 2013). Briefly, 
pruritic compounds were subcutaneously injected into the nape of the neck (50µl). Behavioral 
responses were video recorded for 30 min. The video recording was subsequently played back in 
slow motion and the number of bouts of scratching with the hindpaw and directed toward the 
injection site, were counted.  
For the hot plate test, a clear plexiglass cylinder was placed on the plate and the mice 
were placed inside the cylinder. The onset of brisk hindpaw lifts and/or flicking/licking of the 
hindpaw was assessed at different temperatures.  
For the tail immersion test, mice were gently restrained in a 50ml conical tube into which 
the mice voluntarily entered. The protruding one-third of the tail was then dipped into a water 
bath of varying temperatures. The latency to respond to the heat stimulus with vigorous flexion of 
the tail was measured.  
For the Hargreaves test, mice were placed under a transparent plastic box (4.5 × 5 × 10 
cm) on a glass floor. The infrared source was placed under the glass floor and the infrared light 
was delivered to the hindpaw. The latency for the animal to withdraw its hindpaw was measured.  
For the Von Frey filament test, mice were placed under a transparent plastic box (4.5 × 5 
× 10 cm) on a metal mesh. Von Frey filaments, each delivering a different bending force, were 
applied to the hind paw using the up-down method and the threshold force corresponding to 50% 
withdrawal was determined.  
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For the chemically induced pain test, cheek injection was used to administer a total 
volume of 10µl of capsaicin and the numbers of front paw wipes were counted in 10 minutes.  
For the rotarod test, each mouse was trained for 5 min at a constant speed of 4 rpm on the 
rotarod (Rotamex, Columbus Instruments). The first trial started at least 1h after training. Every 
day, each mouse received three trials, separated by 30 min, at speeds accelerating from 4 to 40 
rpm (with a 4 rpm increase every 30 s). Each mouse was tested for three consecutive days. The 
trial was finished when the mouse fell off the rotarod. The latency to falling off the rotarod was 
recorded and used in subsequent analyses. 
For capsaicin mediated activation experiments, GrpCre; ROSA26LSL-TrpV1; TrpV1-/- mice 
were intrathecally injected with 10µl capsaicin of different concentrations or capsaicin with 
naloxone (0.1mg/ml), naltrindole (0.2mg/ml), CTAP (0.5mg/ml), CTOP (1mg/ml), cycloSOM 
(0.1mM) and bicuculline (10µM). High definition videos were recorded from the top for 30 
minutes with four mirrors to enable views of all angles. Video recordings were subsequently 
played back at 1/5 normal speed. The durations of licking directed to lower back region with a 
characteristic frequency of 5Hz were quantified in the first four minutes and bouts of scratching 
were counted in 30 minutes. ROSA26LSL-TrpV1; TrpV1-/- littermates were used as controls. Wild 
type and TrpV1-/- mice were also intrathecally injected with GRP, BNP and capsaicin. Licking 
and scratching behaviors quantified as reference.  
Light activation of MrgprA3+ neurons: MrgprA3Cre; ROSA26LSL-ChR2 mice with shaved 
nape regions were given 100 ms blue light at 1Hz or 5Hz and litter mate ROSA26LSL-ChR2 mice 
were used as controls. Scratching bouts were counted in 5 minute time period. Sham operations 




GrpCre; ROSA26LSL-TrpV1; TrpV1-/- mice and ROSA26LSL-TrpV1; TrpV1-/- littermate controls 
were deeply anesthetized with isoflurane, decapitated and the lumbar spinal cord was quickly 
removed to ice-cold, low-sodium Krebs solution which contain: 95mM NaCl, 2.5mM KCl, 
26mM NaHCO3, 1.25mM NaH2PO4-H2O, 6mM MgCl2, 1.5mM CaCl2, 25mM glucose, 50mM 
sucrose, 1mM kynurenic acid bubbled with 95% O2/5% CO2. Spinal cords were cut into three 
sagittal sections and then recovered in oxygenated ACSF for about 1h at 37°C. Three sections 
were subsequently incubated with 200µl oxygenated Krebs solution (125mM NaCl, 2.5mM KCl, 
26mM NaHCO3, 1.25mM NaH2PO4-H2O, 1mM MgCl2, 2mM CaCl2, 25mM glucose) with 
capsaicin (2mg/ml, 5µg/ml and 0µg/ml, respectively) and proteinase inhibitor mix (1µM 
phosphoramidon, 1µM captopril and 0.1% BSA) for 15 minutes at 37°C. 100µl of ACSF from 
each sample was then used for the detection of Enkephalin release. ELISA detections of 
enkephalin were performed following manufacturer’s protocol (FEK02421, Phoenix 
Pharmaceuticals). Results were normalized to the weight of the tissue. At least six mice were 
used for each condition. 
Statistical analysis 
Data are presented as mean ± s.e.m. n represents the number of mice analyzed. The 
distribution of the variables in each experimental group was approximately normal. Most 
statistical comparisons were conducted by two-tailed, unpaired Student's t test. Extended Welch’s 
t test was used for the comparison of ratios of ablated responses and control responses. Power 
analysis was used to justify the sample size. Differences were considered to be statistically 
significant for P < 0.05. Representative data are from experiments that were replicated 
biologically at least three times with similar results. 
Extension of Welch’s t test: µ1h: mean of log value of ablated responses, high dose; µ1l 
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mean of log value of ablated responses, low dose; µ2h: mean of log value of control responses, 
high dose; µ2l: mean of log value of control responses, low dose. Null hypothesis H0: (µ1h − µ2h) 
− (µ1l − µ2l) = 0. Alternative H1: (µ1h − µ2h) − (µ1l − µ2l) > 0. Test statistics: 
! = !!"!!!" !(!!!!!!!)
!













, where !! denotes the sample variance and n is the sample size. 
























Dose response curve fitting for capsaicin mediated activation:  
Itch dose responses were fit with Hill equation: y=7.946+ !"#.!"#
!!!" !.!"#!! ×!.!!""
 
Pain dose responses were fit with polynomial equation: y=0.469 − 3.882! + 11.38!! −
1.904!! + 0.08229!! 
 
Results 
Genetic labeling of itch secondary neurons in the spinal cord 
Previously we found that MrgprA3+ itch selective primary sensory neurons terminate 
their axons in lamina II of spinal cord(Han et al., 2013). To identify genetic markers of secondary 
neurons which form synapses directly with MrgprA3+ neurons, we utilized transgenic mouse lines 
with Cre recombinase expression under specific neuronal gene promoters, generated using 
bacterial artificial chromosome (BAC)-based transgenic technology by the Gene Expression 
Nervous System Atlas (GENSAT) project(Gong et al., 2003). Upon screening all GENSAT Cre 
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lines with expression in the spinal cord dorsal horn, we focused on a promising target, Grp. Grp 
has previously been implicated in itch transmission. Grp was reported to express in DRG but not 
spinal cord and proposed to provide input to GRPR+ neurons(Sun and Chen, 2007). However, 
recent studies suggest that Grp instead expresses in spinal cord dorsal horn, not the DRG(Fleming 
et al., 2012; Solorzano et al., 2015). 
Consistent with the recent studies, we found GrpCre expression was restricted to the 
superficial lamina of the spinal cord and we could not detect GrpCre expression in DRG (Figure 
2.2 A and B), when visualized with ROSA26LSL-tdTomato reporter line. To further determine the 
laminar distribution of the Grp+ neurons in the dorsal horn, we performed immunostaining on 
GrpCre; ROSA26LSL-tdTomato spinal slides. Grp+ neurons were located deeper than the CGRP-labeled 
lamina II outer layer (Figure 2.2E), co-localized with IB4 positive fibers in lamina II dorsal inner 
layer (Figure 2.2F) and partially overlapped with PKCγ neurons in ventral inner layer(Braz et al., 
2014; Solorzano et al., 2015) (Figure 2.2G). Since there are no projection neurons in lamina 
II(Todd, 2010), Grp thus labels a subset of interneurons in the lamina II inner layer. Regarding 
neurotransmitter types, more than 90% of Grp+ neurons expressed the glutamatergic excitatory 
marker (Figure 2.2H and K), vesicular glutamate transporter (vGlut2), as labeled by 
vGlut2Cre(Vong et al., 2011). Less than 10% of Grp+ neurons overlapped with the GABAergic 
inhibitory marker, GAD1 (Figure 2.2I), when visualized with GAD1EGFP(Chattopadhyaya et al., 




Figure 2.2 Genetic labeling of itch secondary neurons in the spinal cord 
(A and B) Spinal cord and DRG sections from GrpCre; ROSA26LSL-tdTomato mice, tdTomato 
fluorescence were visualized directly without staining. (C and D) GrpCre; ROSA26LSL-
tdTomato;GrpEGFP and MrgprA3Cre; ROSA26LSL-tdTomato; GrpEGFP spinal sections stained with GFP 
antibody. (E-G) GrpCre; ROSA26LSL-tdTomato spinal sections stained with antibodies to CGRP, IB4 
and PKCγ respectively. (H and I) GrpCre; ROSA26LSL-tdTomato; Gad1EGFP and vGlut2Cre; ROSA26LSL-
tdTomato; GrpEGFP spinal sections stained with GFP antibody. (J) Representative image of biocytin 
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labeled individual Grp+ neurons. (K) Percentage of Grp+ neurons expressing vGlut2 and Gad1. 
n= 15 hemisections from three mice per group. Data are represented as mean ± SEM. All scale 
bars represent 20 µm. Arrowhead indicates overlap. (L) Diagram summarizing the potential 
synaptic connections between MrgprA3+ DRG neurons and Grp+ neurons in the spinal cord.  
 
To check the prevalence of Grp+ neurons in the spinal cord, we stained for pan-neuronal 
marker, NeuN. Grp labeled only 4.24% of neurons in lamina II (Figure 2.3), estimated to be 
about 1% of total dorsal horn neurons(Todd et al., 1998). Moreover, Grp+ neurons were all 
characterized as vertical neurons according to morphology(Grudt and Perl, 2002) (Figure 2.2J, 
n=19). Such a small group of genetically labeled neurons with uniform morphologies more likely 
have uniform functions. Thus the GrpCre line from GENSAT serves as a great tool to investigate 
this small subset of spinal interneurons.  
GENSAT had another Grp line with EGFP expression under the same promoter. We 
crossed the EGFP line with GrpCre; ROSA26LSL-tdTomato. GrpCre expression largely overlapped with 
GrpEGFP (Figure 2.2C and 2.3), confirming that the two BAC lines label the same subset of dorsal 
horn neurons. We found that GrpEGFP overlapped with MrgprA3 central terminals in the spinal 
cord. Moreover, GrpEGFP co-localized with both MrgprA3 and post-synaptic marker PSD95 
(Figure 2.3), suggesting that Grp+ neurons likely form synaptic contacts with MrgprA3-labeled 




Figure 2.3 Further characterization of Grp+ neurons 
(A) Spinal cord sections from GrpCre; ROSA26LSL-tdTomato mice, tdTomato fluorescence were 
visualized directly without staining. (B) NeuN staining. (C) Co-localization of Grp+ neurons and 
NeuN staining. (D) Grp+ neurons represent 4.24% lamina II neurons (n = 25 hemisections from 
five mice). (E) Co-localization of Grp+ neurons with MrgprA3 and PSD95. (F) Representative 
neurons in boxed region in E shown at greater magnification. Arrowheads indicate co-localization 
of Grp+ neurons with MrgprA3 central terminals and synaptic marker PSD95. Data are 
represented as mean ± SEM. All scale bars represent 20 µm. 
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Grp+ neurons receive direct synaptic inputs from itch-selective primary neurons 
Next, to examine the synaptic inputs to Grp+ neurons, we recorded from Grp+ neurons in 
spinal slides while electrically stimulating the dorsal root. All Grp+ neurons had monosynaptic 
inputs from C fibers with short synaptic delays (Figure 2.5), demonstrating that Grp exclusively 
labels secondary neurons with direct synaptic input from DRG. We then tried to further determine 
the source of C fiber inputs onto Grp+ neurons. To directly test whether Grp+ neurons receive 
direct synaptic input from MrgprA3+ neurons, we crossed MrgprA3Cre with Cre dependent 
Channelrhodopsin reporter line ROSA26LSL-ChR2 to selectively activate MrgprA3 fibers with blue 
light (as diagramed in Figure 2.4A).  
To examine the behavioral effect of light-mediated activation of the MrgprA3+ neurons, 
we shone blue light on the shaved nape regions of MrgprA3Cre; ROSA26LSL-ChR2 mice (as 
diagramed in Figure 2.4A). 1Hz 100ms light stimulation generated significant scratching 
compared with controls (Figure 2.4B). Similar to chemical activation(Han et al., 2013), 
optogenetic activation generated only scratching behavior, which confirmed the role of MrgprA3+ 
neurons as itch-selective neurons. 5Hz light stimulation, however, failed to elicit scratching above 
baseline (Figure 2.4B and 2.5). Consistently, 1Hz light stimulation reliably evoked action 
potentials in MrgprA3+ neurons, while 5Hz light stimulation failed to do so (Figure 2.5), 





Figure 2.4 Grp+ neurons receive monosynaptic itch input 
(A) Left: diagram showing light activation of MrgprA3 peripheral fibers in behavioral tests; right: 
diagram showing light activation of MrgprA3 central terminals and recording of Grp+ neurons in 
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the spinal cord. (B) 1Hz and 5Hz 100ms light stimulation triggered scratching bouts in five 
minutes. MrgprA3Cre; ROSA26LSL-ChR2 and ROSA26LSL-ChR2 control mice with light delivered to 
shaved nape regions (n=6). Data are represented as mean ± SEM. (C) From left to right: image of 
Grp+ neurons in spinal slice with electrode (black lines), representative traces of light-induced 
EPSCs in Grp+ neurons with monosynaptic input from MrgprA3+ neurons and percentage of 
Grp+ neurons with monosynaptic input from MrgprA3+ neurons. (D) Left: representative traces of 
light-induced EPSCs in lamina II Grp negative neurons with monosynaptic input, polysynaptic 
input and no synaptic input from MrgprA3+ neurons. Right: percentage of lamina II Grp negative 
neurons with monosynaptic input, polysynaptic input and no synaptic input from MrgprA3+ 
neurons. Recordings done by Dr. Qian Xu. 
 
When we recorded from the Grp+ neurons while stimulating the MrgprA3 central 
terminals with light, 100% of the Grp+ neurons (16/16) received monosynaptic input from 
MrgprA3+ neurons (Figure 2.4C and 2.5), suggesting that Grp+ neurons labeled a functionally 
unified population of secondary neurons that all receive direct itch input from the periphery. 
When we recorded from surrounding Grp negative neurons, 25% of them (7/28) also received 
monosynaptic input, an additional 18% (5/28) received polysynaptic input and the remaining 57% 
(16/28) had no connection with MrgprA3+ neurons (Figure 2.4D and 2.5), suggesting that Grp 






Figure 2.5 Light-mediated MrgprA3 activation and monosynaptic input to Grp+ neurons 
(A) Light-evoked action potentials in cultured MrgprA3Cre; ROSA26LSL-ChR2 DRG neurons. * 
indicates failure of action potential. (B) Continuous and 1Hz light induced responses in current 
clamp and voltage clamp mode. Blue bars indicate 5ms light stimulation. (C) Light-induced 
scratching bouts in MrgprA3Cre; ROSA26LSL-ChR2 (test, n=6) compared with sham responses with 
no light (baseline, n=6). **: P<0.01, two-tailed unpaired Student's t test. (D) 100% of Grp+ 
neurons (n=14) received C fiber monosynaptic input. Representative traces shown in middle. (E) 
EPSC jitters of Grp+ neurons and Grp negative neurons with polysynaptic connections with 









Figure 2.6 Monosynaptic retrograde tracing from Grp+ neurons 
(A) Diagram showing monosynaptic retrograde tracing strategy from Grp+ neurons. (B) Rabies-
labeled neurons overlap with IB4 in spinal cord. (C) Top panels: L4-6 DRG sections labeled with 
different markers (CGRP, IB4, NF200, MrgprC11 and TrpV1). Middle panels: rabies virus trans-
synaptically labeled DRG neurons. Bottom panels: merge images. Arrowhead indicates overlap 
of markers and rabies-labeled DRG neurons. All scale bars represent 20 µm. (D) Percentage of 
rabies trans-synaptically labeled DRG neurons co-localize with different markers. Pooled results 
from more than 30 DRG sections of at least five mice for each marker.  
 
We then tried to determine whether Grp+ neurons receive other somatosensory input, 
such as input from nociceptors in DRG. However, it is hard to selectively activate nociceptors 
without also targeting the itch-selective neurons, given that they share many genetic markers. 
Therefore we decided to use mono-synaptic rabies tracing(Wickersham et al., 2007) to 
systemically quantify the inputs to the Grp+ population. AAV helper virus (AAV8-LSL-TVA-
EGFP-B19G) was injected into the spinal cord to enable expression of TVA receptor and rabies 
glycoprotein in Cre expressing neurons. Deficient rabies virus (ΔG-RV-GFP) specifically 
infected the Grp+ neurons which expressed TVA. The Grp+ neurons also contained the rabies 
glycoprotein that allowed the virus to be transported from the Grp+ neurons only to their 
presynaptic targets (as diagramed in Figure 2.6A). 
Deficient rabies virus successfully infected neurons in spinal cord lamina II of GrpCre 
mice (Figure 2.6B) but not in Cre negative mice or when injected without the helper virus (Figure 
2.7), showing the specificity of viral tracing. In DRG, rabies virus trans-synaptically labeled 
mostly small to medium diameter neurons. 64.1% of rabies labeled DRG neurons expressed 
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peptidergic marker calcitonin gene-related peptide (CGRP), 39.3% of rabies labeled DRG 
neurons expressed non-peptidergic marker IB4, while very few (3.85%) expressed myelinated 
neuronal marker NF200 (Figure 2.6C and D). We utilized an available MrgprC11 antibody, 
which marks an itch population containing most MrgprA3+ neurons(Han et al., 2013) and showed 
that these neurons are indeed trans-synaptically labeled, confirming that Grp+ neurons received 
monosynaptic input from itch-selective neurons. However, only 22.3% of rabies-labeled neurons 
were MrgprC11 positive, while 50.0% of rabies-labeled neurons were positive for nociceptive 
marker, TrpV1(Figure 2.6D). Even though most Mrgpr+ neurons also expressed CGRP, IB4 and 
TrpV1, the fact that these markers labeled much more rabies-infected neurons demonstrated that 
not only itch-selective neurons, but also nociceptive populations provide monosynaptic inputs to 
Grp+ neurons. 
 
Figure 2.7 Single synapse retrograde tracing from Grp+ neurons 
(A) Rabies virus (green) infected Grp+ neurons labeled by tdTomato fluorescence and 
surrounding neurons representing presynaptic targets of Grp+ neurons. (B and C) Rabies virus 
cannot infect spinal cord neurons without helper virus or in Cre negative control mice. All scale 





Painful stimuli strongly while itchy stimuli weakly activate Grp+ neurons 
Since Grp+ neurons receive direct synaptic inputs from both itch and pain primary 
sensory neurons, we next tried to determine whether Grp+ neurons can distinguish between pain 
and itch inputs. We performed DRG-attached spinal slice recordings and applied drugs on DRG 
cell bodies to mimic natural painful and itchy stimuli coming from the periphery (Figure 2.8A). 
Both pain- and itch-producing drugs applied directly on DRG triggered action potentials in Grp+ 
neurons (Figure 2.8C-E). Capsaicin evoked high frequency firing in Grp+ neurons; while the 
pruritogen SLIGRL produced only weak firing. To confirm that limited penetration of peptide 
SLIGRL did not affect the responses of Grp+ neurons, we applied a small molecule pruritogen, 
histamine. Similarly, histamine generated only weak firing in Grp+ neurons, which suggests that 
these neurons fire strongly in response to painful stimuli but weakly in response to itchy stimuli 




Figure 2.8 Painful stimuli strongly activate while itchy stimuli weakly activate Grp+ neurons 
(A) Image of DRG attached spinal cord slice. Recording electrode on right and drug application 
electrode on left. (B) Diagram summarizing painful stimuli from DRG can strongly activate Grp+ 
neurons while itchy stimuli can only weakly activate Grp+ neurons. (C-E) Top panels: 
representative traces of action potentials from Grp+ neurons in responses to drugs. Bottom panels: 
Grp+ neurons in response to capsaicin, histamine and SLIGRL application on DRG. Black bar 
indicates duration of drug application (n=6). Data are represented as mean ± SEM. Recordings 
done by Dr. Qian Xu. 
 
Coding of both pain and itch by Grp+ neurons 
Although the itch neurons in DRG are responsive to both painful and itchy stimuli, 
activation of these neurons generates itch, not pain responses(Han et al., 2013). Similarly, Grp+ 
neurons receive direct synaptic inputs from both pain and itch primary neurons. Using behavioral 
assays, we next determined what sensations are generated by the activation of Grp+ neurons. To 
specifically activate Grp+ neurons, we crossed GrpCre to ROSA26LSL-TrpV1 in a global TrpV1 
knockout background (GrpCre; ROSA26LSL-TrpV1; TrpV1-/-). In GrpCre; ROSA26LSL-TrpV1; TrpV1-/- 
mice, TrpV1 agonist capsaicin selectively activated Grp+ neurons, the only cells with TrpV1 
expression (as diagramed in Figure 2.8A). To test the functional expression of TrpV1, we injected 
AAV1-LSL-tdTomato virus into the spinal cord and recorded from tdTomato labeled Grp+ 
neurons. Labeled neurons from GrpCre; ROSA26LSL-TrpV1; TrpV1-/- but not from GrpCre; TrpV1-/- 
mice responded to capsaicin (Figure 2.10). Grp+ neurons with ectopic TrpV1 expression showed 
lower sensitivity to capsaicin compared with TrpV1+ DRG neurons. These neurons exhibited 
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monotonically increased responses to a wide range of capsaicin doses (Figure 2.10), confirming 




Figure 2.9 Intensity dependent coding of pain and itch by Grp+ neurons 
(A) Diagram showing the strategy of capsaicin-mediated specific activation of Grp+ neurons in 
GrpCre; ROSA26LSL-TrpV1; TrpV1-/- mice. (B and C) Pain-related licking time and itch-related 
scratching bouts in wild type (green bars) and TrpV1-/- mice (red bars) triggered by intrathecal 
delivery of 10µl capsaicin (1µg, n=6), BNP (25µg, n=8) and GRP peptides (200µM, n=8). (D and 
E) 10µl intrathecal capsaicin-triggered pain and itch responses in GrpCre; ROSA26LSL-TrpV1; TrpV1-
/- mice (black bars, from left to right: 10ng, n=9; 50ng, n=6; 0.2µg, n=5; 1µg, n=6; 5µg, n=10; 
20µg, n=6) together with responses in wild-type (green bars, 1µg, n=6) and TrpV1-/- mice (red 
bars, 5µg, n=6) from (B and C). (F and G) 10µl intrathecal capsaicin-triggered pain and itch 
responses in GrpCre; ROSA26LSL-TrpV1; TrpV1-/- mice with drugs. From left to right 1µg capsaicin 
without and with GRPR antagonist (Deamino-Phe19,D-Ala24,D-Pro26-psi(CH2NH)Phe27)-GRP 
(19-27), 200µM, n=6 and 5); 10µg capsaicin, n=8; 10µg capsaicin with naloxone (1µg, n=7), 
naltrindole (10µg, n=7), CTAP (5µg, n=6), CTOP (10µg, n=6), bicuculline (10µM, n=7), 
cycloSomatostatin (0.1mM, n=8) and for (F) 5µg/ml capsaicin without (n=6) and with naloxone 
(1µg, n=9). (H and I) Pain and itch dose-response curve fitting of (D and E). (J) Enkephalin 
release with different doses of capsaicin from GrpCre; ROSA26LSL-TrpV1; TrpV1-/- mice (black bars) 
and ROSA26LSL-TrpV1; TrpV1-/- control mice (blue bars) normalized to per g tissue used in ELISA. 
(K) Comparison of “leaky gate” model (left) and the gate control theory (right). Yellow 
rectangles indicate type I incoherent feed forward loop formed by Grp+ neurons and Aβ fibers 
respectively. Data are represented as mean ± SEM. *: P < 0.05, **: P<0.01, ***: P<0.001, two-
tailed unpaired Student's t test. Abbreviations: WT short for wild type. KO short for TrpV1-/-. 
Grp-V1;V1KO short for GrpCre; ROSA26LSL-TrpV1; TrpV1-/-, Enke short for Enkephalin, T short for 




To better interpret the behavioral responses, we used wild-type mice to first test drugs 
known to produce pain (capsaicin) and itch (gastrin releasing peptide, GRP and brain natriuretic 
peptide, BNP) responses when given intrathecally. The behavior chamber was surrounded by four 
mirrors on opposing sides and behaviors were recorded with a high-definition camera located 
above the chamber. This enabled the behavior to be viewed and captured from all angles (Figure 
2.10)(LaMotte et al., 2011). When we played back videos at 1/4 normal speed, distinct behavioral 
responses to pain- and itch-producing drugs were observed in wild-type mice. Capsaicin 
generated extensive licking directed to the lower back regions at a characteristic frequency of 5Hz, 
but no scratching. This licking behavior usually stopped within 5 minutes of injection and was 
absent in TrpV1-/- mice, suggesting the specificity of this licking response. GRP and BNP, 
however, produced scratching that lasted about 30 minutes after injection, but no licking.  
Surprisingly, the activation of Grp+ neurons in GrpCre; ROSA26LSL-TrpV1; TrpV1-/- mice by 
intrathecal capsaicin generated both pain-related licking and itch-related scratching; capsaicin 
generated no response in Cre negative control mice (ROSA26LSL-TrpV1; TrpV1-/-) and only pain-
related licking in wild-type mice (Figure 2.9B and C), which confirms the specificity of the 
activation responses. The licking responses lasted only about 4 minutes after injection (similar to 
the licking responses in wild-type mice) and were not affected by a GRPR antagonist (Figure 
2.9D and F); the scratching responses lasted more than 30 minutes and were effectively blocked 
by GRPR antagonist (Figure 2.9E and G). This result confirms previous reports that neurons 
expressing GRPR are important for the transmission of itch sensation. Thus the activation of Grp+ 
neurons can trigger both robust pain and itch responses, a phenomenon rarely observed. Unlike 
itch-selective neurons in DRG, Grp+ neurons receive monosynaptic inputs from both itch and 
pain neurons and code for both itch and pain, showing unexpected convergence of two related 
sensations in the spinal cord. 
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Intensity dependent coding of pain by Grp+ neurons 
Next, we used a dose-response curve to examine the relationship between Grp+ neuron 
activation and behavior. Increasing doses of capsaicin increased itch responses until a plateau was 
reached while pain responses, surprisingly, showed an inverted U relationship (Figure 2.9D and 
E). Increased capsaicin resulted in increased licking time that peaked and then decreased with 
higher capsaicin doses. Weak and strong activation produced little pain while medium range 
activation generated optimal pain responses. Given that high doses of capsaicin still caused robust 
itch responses, the inverted U pain responses were unlikely caused by desensitization. Thus Grp+ 
neurons demonstrate intensity-dependent coding. Rather than generating itch sensation with weak 
activation and pain sensation with strong activation, as suggested by the original intensity theory, 
Grp+ neurons monotonically code for itch while pain is coded only by a certain range of inputs. 
When we tried to fit the Grp activation dose response curves, the itch responses fitted 
nicely to the Hill equation (R2=0.97, Figure 2.9I), while the pain responses, perhaps not 
surprisingly, did not assume sigmoidal shape. Instead, the pain responses fitted well with a 
polynomial equation (R2=0.99, Figure 2.9H). Non-monotonic dose responses, such as hormesis 
responses, are usually modeled with polynomial equations(Bailer and Oris, 1997, 1998). The 
typical inverted U dose response curve of hormesis is generated by low dose stimulation and high 
dose inhibition effect of the same drug(Calabrese and Baldwin, 2003), suggesting that similar 
antagonizing actions might underlie the pain response curve generated by the activation of Grp+ 
neurons. 
To further explore the mechanisms underlying this novel inverted U coding of pain, we 
tried to “rescue” pain responses during strong activation of the Grp+ neurons. An opioid 
antagonist, naloxone, at a dose not eliciting pain itself, “rescued” the pain responses from almost 
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zero to about half of the maximal level. Both bicuculline , a GABA A antagonist, and cyclo-
somatostatin, the antagonist of anti-nociceptive somatostatin highly expressed in the surrounding 
region, failed to “rescue” the pain responses (Figure 2.9F). Successfully rescuing pain responses 
again confirmed that Grp+ neurons were not desensitized by high doses of capsaicin. Naloxone 
had no effect on itch responses (Figure 2.9G), demonstrating the specificity of the “rescue” effect. 
To demonstrate that naloxone was not simply blocking the basal activity of the endogenous 
opioid system, independent of Grp activation, we co-injected naloxone with a low dose of 
capsaicin which can produce both medium pain and itch responses. No effect was observed on 
pain responses (Figure 2.9F), showing that the endogenous opioid system is only recruited to 
inhibit pain during strong activation of the Grp+ neurons. The data suggest that the endogenous 
opioid system is at least partially responsible for the pain inhibition associated with strong 
activation of the Grp+ neurons and therefore, together with direct pain coding by the Grp+ 




Figure 2.10 Capsaicin-mediated activation of Grp+ neurons and co-localization of Grp+ 
neurons and enkephalin-expressing neurons 
(A) Photo showing behavior chamber with four mirrors on opposing sides with high-definition 
camera recording video from above. (B) AAV1-LSL-tdTomato virus labeled neurons from 
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GrpCre; ROSA26TrpV1; TrpV1-/- spinal cord. (C) Representative traces of capsaicin-induced EPSCs 
in Grp+ neurons of GrpCre; ROSA26LSL-TrpV1; TrpV1-/- spinal slices. Black bars indicate capsaicin 
application. (D) Capsaicin dose responses of Grp+ neurons ectopically expressing TrpV1 (n=6 
each dose). Recordings done by Dr. Qian Xu. (E) Co-localization of Grp+ neurons with 
Enkephalin-expressing neurons and PSD95. (F) Representative neurons in boxed region in E 
shown at greater magnification. Arrowheads indicate Grp+ neurons co-localized with Enkephalin 
and synaptic marker PSD95. Data are represented as mean ± SEM. All scale bars represent 20 µm. 
 
We determined which endogenous opioid peptide was employed to block pain by 
utilizing mu opioid antagonist CTAP and CTOP and delta opioid antagonist naltrindole. 
Naltrindole but not CTAP or CTOP induced a similar rescue effect as naloxone (Figure 2.9F), 
while none of the drugs affected itch responses (Figure 2.9G). These results link enkephalin, the 
endogenous ligand for delta opioid receptors, to this pain inhibition effect. Indeed, enkephalin 
release was detected with ELISA when GrpCre; ROSA26LSL-TrpV1; TrpV1-/- spinal cords were 
treated with high dose capsaicin but not detected with low dose or no capsaicin (Figure 2.9J). 
Furthermore, spinal cord from Cre negative control mice (ROSA26LSL-TrpV1; TrpV1-/-) treated with 
high dose capsaicin released a minimal amount of enkephalin, which confirms that the release of 
enkephalin is dependent on strong activation of the Grp+ neurons. To test whether Grp+ neurons 
are synaptically connected with enkephalin-expressing interneurons in the spinal cord, we 
performed triple labeling of Grp+ neurons (tdTomato), enkephalin and synaptic marker PSD95. 
Co-localizations of these three markers suggest that enkephalin-expressing interneurons may 
receive synaptic input from Grp+ neurons (Figure 2.10). Moreover, enkephalin, like most 
neuropeptides, is stored in large dense core vesicles that require strong depolarization for 
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release(Cesselin et al., 1984; Neuman et al., 1984). This is consistent with the observation that 
only strong activation of the Grp+ neurons triggers pain inhibition.  
Grp+ neurons form “leaky gate” to negatively regulate pain transmission 
In short, activation of the Grp+ neuron population codes for pain but also inhibits pain 
through the release of enkephalin, forming a type I incoherent feed forward loop (summarized in 
Figure 2.13B). Feed forward loop (FFL) is a common network motif highly represented in 
biological networks such as neuronal circuitries(Alon, 2007; Milo et al., 2002). The type I 
incoherent FFL, featuring direct activation and indirect inhibition of the same output, functions to 
generate non-monotonic responses, such as the inverted U response curve(Kaplan et al., 2008). A 
circuit with the inverted U response curve works as an amplitude filter to transmit signals only in 
a certain range(Entus et al., 2007), which is consistent with the pain behavioral responses 
associated with Grp activation.  
A type I incoherent FFL that is related to pain is demonstrated in the gate control 
theory(Melzack and Wall, 1965; Wall, 1978). The gate control theory of pain proposes that 
nociceptive transmission neurons (T) receive both noxious input from C fibers and non-noxious 
input from Aβ fibers. Aβ input also indirectly inhibits nociceptive transmission neurons through 
inhibitory interneurons (IN). Thus Aβ fibers form a type I incoherent feed forward loop to control 
pain transmission (Figure 2.13A). The indirect inhibition through IN can close the “gate” (T) and 
suppress painful input.  
Here, we propose a model to explain our experimental observations and then provide 
more data to support the model. Similar to Aβ fibers in the gate control theory, we propose that 
Grp+ neurons can use the type I incoherent feed forward loop as a “gate” to regulate pain 
transmission. When strongly activated, Grp+ neurons can trigger enkephalin release to close the 
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“gate” to painful signals from both Grp+ neurons and potentially other pain- sensing neurons in 
the spinal cord, resulting in reduced pain sensation (summarized in Figure 2.13B). However, the 
Aβ and Grp gates have some fundamental differences. The Aβ FFL does not let any signals 
through the “gate”, at least under physiological conditions, so that non-noxious input does not 
elicit pain sensations; the Grp FFL allows weak pain signals to pass through the “gate” but 
suppresses strong pain signals. Therefore, we named it a “leaky” gate. We think the advantage of 
this “leaky gate” is that passing on weak signals ensures sensitivity to weak painful stimuli while 
inhibiting strong signals prevents overwhelming pain sensations. 
Increased pain and decreased itch after ablation of Grp+ neurons 
According to our “leaky gate” model, the Grp FFL functions as a “brake” to prevent 
strong pain signals from overwhelming the system. Therefore, we predicted that the loss of the 
Grp+ neurons should lead to an increase of pain responses. To directly test this prediction, we 
ablated Grp+ neurons with diphtheria toxin. Diphtheria toxin receptors (DTRs) were specifically 
expressed in Grp+ neurons with Cre dependent ROSA26LSL-DTR line together with ROSA26LSL-
tdTomato allele to monitor ablation efficacy (Figure 2.11A). Diptheria toxin treatments successfully 
ablated more than 95% of the Grp+ neurons (Figure 2.11B and C). Cre negative mice 
(ROSA26LSL-DTR/LSL-tdTomato) treated with same doses of diphtheria toxin were used as controls. 
Ablated mice were generally healthy and had normal motor coordination in the rotarod test 
(Figure 2.12). In addition, CGRP and IB4 labeled lamina II regions showed no change after 
ablation, suggesting that the loss of such a small population did not affect general organization of 
the local circuitries. The number of PKCγ positive neurons was reduced, consistent with the 
partial overlap between PKCγ and Grp+ neurons while the number of Pax2+ interneurons were 
comparable between ablated and control mice, confirming that diphtheria toxin treatment did not 
produce non-specific neurotoxicity (Figure 2.12).  
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First, we tested acute pain responses. Chemical pain induced by capsaicin cheek 
injections greatly increased after ablation (Figure 2.11E, yellow shaded). GrpCre; ROSA26LSL-
DTR/LSL-tdTomato mice also had significantly shorter response time in all thermal pain assays including 
hot plate, Hargreave and tail immersion when compared with control mice (Figure 2.11E). 
Mechanical sensitivity tested by Von Frey filaments remained the same in both genotypes (Figure 
2.11F). Thus, loss of Grp+ neurons enhanced chemical and thermal pain, as predicted by the 
“leaky gate” model. We next tested itch responses.	  Scratching responses to multiple pruritogens 
including histamine (100mM), Chloroquine (CQ, 4mM), SLIGRL (1mM) and serotonin (5-HT, 
1mM) were all significantly reduced in GrpCre; ROSA26LSL-DTR/LSL-tdTomato mice, confirming the 




Figure 2.11 Increased pain and decreased itch responses after the ablation of Grp+ neurons 
(A) Diagram showing ablation of Grp+ neurons in the spinal cord. (B) Representative images of 
GrpCre; ROSA26LSL-DTR; LSL-tdTomato spinal slices with and without diphtheria toxin treatments. All 
scale bars represent 20 µm. (C) Quantification of Grp+ neurons per five 20µm hemisections in 
GrpCre; ROSA26LSL-DTR; LSL-tdTomato (red) and ROSA26LSL-DTR; LSL-tdTomato control mice (blue) after 
diphtheria toxin treatments (n=5 mice). (D) Scratching bouts induced by histamine (100mM, n=6 
vs. 8), serotonin (1mM, n=7 vs. 8), SLIGRL (1mM, n=7) and chloroquine (4mM, n=11 vs. 9) 
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injection in the nape region (50µl) in GrpCre; ROSA26LSL-DTR; LSL-tdTomato (red) and ROSA26LSL-DTR; 
LSL-tdTomato control mice (blue). (E) Pain responses from Hargreaves test (n=8 vs. 7), capsaicin 
cheek injections (1mg/ml, n=8; 0.5mg/ml, n=7 vs. 6), hot plate test (52°C, n=10; 55°C, n=7 vs. 6) 
and tail immersion tail (50°C, n=7 vs. 6; 52°C, n=7 vs. 6) in GrpCre; ROSA26LSL-DTR; LSL-tdTomato 
(red) and ROSA26LSL-DTR; LSL-tdTomato control mice (blue). Yellow shaded regions represent 
responses with strong stimuli. (F) Von Frey test responses (n=11) in GrpCre; ROSA26LSL-DTR; LSL-
tdTomato (red) and ROSA26LSL-DTR; LSL-tdTomato control mice (blue). (G) Diagram summarizing the role 
of Grp+ neurons in pain and itch coding. Grp+ neurons receive weak input from itchy stimuli and 
strong input from painful stimuli, and positively code for itch while negatively regulate pain 
transmission. Data are represented as mean ± SEM. *: P < 0.05, **: P<0.01, ***: P<0.001, 
extended Welch’s t test for response ratio comparison between different temperatures in hot plate 
and tail immersion test and two-tailed unpaired Student's t test for the rest. Abbreviations: 
Grp/DTR/tdt short for GrpCre; ROSA26LSL-DTR; LSL-tdTomato and DTR/tdt short for ROSA26LSL-DTR; LSL-










Strong pain responses are more affected by the loss of Grp+ neurons 
 
Figure 2.12 DTX treatment did not produce neurotoxic effects 
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(A and B) Representative images of GrpCre; ROSA26LSL-DTR; LSL-tdTomato (ablation) and ROSA26LSL-
DTR; LSL-tdTomato (control) spinal cords stained with CGRP and IB4. (C and D) Representative images 
of PKCγ and Pax2 positive neurons in GrpCre; ROSA26LSL-DTR; LSL-tdTomato (ablation) and 
ROSA26LSL-DTR; LSL-tdTomato (control) spinal cords. Quantification on right panels. **: P<0.01, two-
tailed unpaired Student's t test. (E) Ablation of Grp+ neurons did not affect motor coordination in 







Figure 2.13 “Leaky gate” model in pain and itch transmission 
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(A) Comparison of “leaky gate” model (left) and the gate control theory (right). Grp+ neurons 
directly code for pain and itch while inhibiting pain through Enkephalin-expressing interneurons. 
Aβ fibers activate pain transmission neurons and also indirectly inhibit pain transmission neurons 
via inhibitory interneurons. Yellow rectangles indicate type I incoherent feed forward loop 
formed by Grp+ neurons and Aβ fibers respectively. (B) Diagram summarizing the role of Grp+ 
neurons in pain and itch coding. Grp+ neurons receive weak input from itchy stimuli and strong 
input from painful stimuli, and positively code for itch while negatively regulate pain 
transmission. Abbreviations: Enke short for Enkephalin, T short for pain transmission neurons, 
IN short for inhibitory interneurons. 
 
We also compared dose effect on itch responses, which are normally coded by the Grp+ 
neurons, between control and ablated mice. Ablated mice showed reduced itch responses to low 
doses of SLIGRL and CQ (Figure 2.11D), while high doses generated similar responses in both 
ablated and control mice (Figure 2.12). Thus in contrast to pain, stronger itch responses are less 
affected by the loss of Grp+ neurons, potentially due to saturation or compensation from other 





The selectivity theory depicts pain and itch coding in the spinal cord as the continuation 
of separate labeled lines from periphery with pain inhibiting itch through B5-I 
interneurons(Kardon et al., 2014) or NPY interneurons(Bourane et al., 2015c). We show that a 
subset of secondary neurons with uniform morphologies, the Grp+ population, participates in the 
coding of both pain and itch sensations. We think this potentially represents the currently 
underappreciated crosstalk of these two sensations in the spinal cord. The difference of circuit 
organizations in DRG and the spinal cord is hinted at by their distinct anatomical structures.  
DRG neurons with pseudo-unipolar organizations and little crosstalk between each other 
resemble labeled lines, while neurons in the spinal cord dorsal horn form an interlacing network, 
enabling crosstalk of incoming information from different sensations.  
Another feature of the Grp+ population is the intensity dependent coding of pain. The 
Grp+ neurons directly code for pain sensation and upon strong activation, indirectly inhibit pain 
via the recruitment of the endogenous opioid system. Only a certain range of input can trigger 
pain sensation via Grp+ neurons. Contrary to the intensity theory, which suggests that different 
intensities differentiate different sensations, the intensity-dependent pain coding by the Grp+ 
neurons reflects a way of pain signal processing in the spinal cord. Unlike classical monotonic 
coding of sensory information, this novel intensity-dependent coding serves as a good example of 
the currently overlooked non-monotonic signal processing by spinal circuits. 
The Grp+ population forms a type I incoherent feed forward loop to regulate pain 
transmission, similar to the role of Aβ fibers in the gate control theory. Both systems function as 
“brakes” for pain. Pain detection systems need to be sensitive enough to protect the body from 
potential harm, but when exposed to strong pain stimuli, high sensitivity could be troublesome. 
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High sensitivity may generate too much pain and interfere with proper behavioral responses. Thus 
brakes are necessary. Brakes triggered by signals from Aβ mechanosensitive fibers makes gentle 
rubbing an effective way to relieve pain, while brakes triggered by pain itself can provide 
negative feedback to prevent overwhelming pain responses. The pain inhibition mediated by Grp+ 
neurons, however, cannot be triggered by itch, since itch stimuli only weakly activate Grp+ 
neurons, consistent with the fact that itch can rarely inhibit pain. 
Unlike the role of Aβ fibers in the gate control theory, the Grp FFL functions as a “leaky 
gate” to pass along weak pain signals and only close the gate to inhibit strong pain signals. Such a 
“leaky gate” can reduce strong pain responses without sacrificing the sensitivity to weak pain 
signals. The pain inhibition mediated by enkephalin is more prominent than the coding of pain by 
the Grp+ population, since the inhibition effect could completely block pain responses from the 
Grp+ population and further reduce pain coded by other pain-sensing neurons in the spinal cord. 
If such strong pain inhibition was triggered also by weak stimuli, it may likely affect pain 
sensitivity. Incoherent feed forward loops can provide diverse response patterns by varying the 
relative strength of the two arms with opposing effects on the output and, thus, are well suited for 
the fine-tuning of sensory responses, as illustrated by the gate control theory and the “leaky gate” 
model. 
The ablation experiments showed that stronger pain responses had bigger increases after 
the ablation of the Grp+ neurons, suggesting that the Grp FFL provides stronger inhibition on 
stronger painful input in physiological conditions, consistent with the “leaky gate” model. 
Theoretically, weak enough painful stimuli might evoke weaker pain responses after the ablation 
of Grp+ neurons, as these painful stimuli do not trigger pain inhibition and thus are positively 
coded by the Grp+ population. However, given that the Grp+ neurons only represent a subset of 
pain responsive neurons in the spinal cord, the loss of these neurons may generate a more subtle 
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change in behavior when compared with the loss of the strong pain inhibition effect mediated by 
the Grp FFL and thus be much harder to detect with animal behavioral tests. In a previous study, 
Mishra et al. ablated 70% of NPR1+ neurons, which were reported to be a subset of Grp+ neurons, 
with BNP conjugated saporin and only found a significant change in histamine responses(Mishra 
and Hoon, 2013). We think the partial loss of Grp+ neurons might not be sufficient to generate 
significant changes in pain responses; however, the response time in the hot plate test did seem to 
show a trend of reduction after the ablation of NPR1+ neurons. 
Evidence suggests that Grp+ neurons are synaptically connected with enkephalin 
expressing neurons, so activation of Grp+ neurons likely triggers enkephalin release from these 
local interneurons. Most enkephalin positive neurons in the spinal dorsal horn are GABAergic 
inhibitory interneurons(Fukushima et al., 2011; Todd et al., 1992). Enkephalin, like other typical 
neuropeptides, is stored in large dense core vesicles and released upon strong, not weak, 
depolarization(Cesselin et al., 1984; Neuman et al., 1984). Therefore, it is strong painful but not 
itchy or weak painful stimuli that can strongly activate Grp+ neurons and further trigger 
enkephalin release in enkephalin positive inhibitory interneurons. This explains the selective 
recruitment of enkephalin by strong painful stimuli. Support of the Grp FFL recruitment of the 
enkephalin system was found by the increase of enkephalin release from spinal cord following 
nociceptive stimuli(Cesselin et al., 1985). 
The Grp+ neurons represent a subset of secondary neurons mediating pain and itch 
sensations in the spinal cord. Painful stimuli from the periphery can elicit both pain and itch 
responses via the Grp+ neurons. The itch responses are likely blocked by feed forward inhibition 
from parallel pain pathways, as stated by the selectivity theory. Similarly, itchy stimuli from the 
periphery can also trigger both itch and pain responses via the Grp+ neurons. The pain responses, 
we think, might be weak, given the weak activation of the Grp+ neurons by itchy stimuli. Indeed, 
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in human psychophysical studies, most itchy substances induce itch sensation accompanied by 
weaker and shorter lasting noxious sensations, such as pricking and burning, while painful 
substances induced nociceptive but not itch sensations(LaMotte et al., 2014; Liu et al., 2012; 
Sikand et al., 2009, 2011a). Thus the “leaky gate” model can explain the nociceptive sensations 
generated by itchy chemicals in human psychophysics studies. However, we cannot rule out the 
possibility that mechanical or other forms of itch can bypass or block the weak pain responses 
and result in pure itch sensation. 
In summary, Grp+ neurons positively code for itch while negatively regulating pain 
transmission with a “leaky gate.” This study, to our knowledge, experimentally demonstrates 
intensity-dependent coding of pain in spinal cord for the first time. It better explains observations 
in human psychophysical studies and serves as a great example of non-monotonic coding and 
fine-tuning of sensory information in spinal cord. The new “leaky gate” model and related 
mechanistic understanding of pain and itch coding may provide valuable information for the 
treatment of devastating chronic pain and chronic itch conditions, as the influential gate control 
theory of pain did.  
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CHAPTER 3: REDEFINING THE CONCEPT OF PROTEASE-ACTIVATED RECEPTORS: 
CATHEPSIN S EVOKES ITCH VIA ACTIVATION OF MRGPRS 
Introduction 
The sensation of itch is relayed from the skin to the brain via a complex but orchestrated 
series of signals. Itch is initiated when exogenous or endogenous pruritogens activate receptors or 
channels on the peripheral projections of primary sensory neurons, the cell bodies of which reside 
in the dorsal root or trigeminal ganglia. Specific members of the family of Mas-related G-protein-
coupled receptors (Mrgprs) are expressed by subsets of nociceptive fibres(Dong et al., 2001). 
These receptors have been shown to bind select pruritogens in the periphery and mediate non-
histaminergic itch(Liu, 2009, 2011). For example, mouse MrgprA3 and human MRGPRX1 
respond to chloroquine, an anti-malarial drug, and are responsible for relaying chloroquine-
induced scratching in mice(Liu, 2009; Wilson et al., 2011). Mouse MrgprC11 and human 
MRGPRX1 respond to a different subset of pruritogens including bovine adrenal medulla peptide 
(BAM8–22). MrgprC11 is activated by SLIGRL and SLIGKV, the tethered ligand peptides of 
respective mouse and human protease-activated receptor-2 (PAR2), while MRGPRX2 is 
activated by SLIGKV(Lembo, 2002; Liu, 2009, 2011; Sikand et al., 2011b). Trypsin, a serine 
protease and conventional activator of PARs, does not activate Mrgprs(Liu, 2011; Ramachandran 
and Hollenberg, 2008).  
In addition, β-alanine, a body-building supplement known to cause itch upon ingestion, 
activates the MrgprD receptor expressed by nociceptive fibres(Liu, 2012). In transgenic mice in 
which a cluster of Mrgprs has been ablated, cutaneous exposure to these pruritogens evokes 
significantly less scratching compared with wild-type (WT) controls. These findings underscore 
the importance of this family of receptors to peripheral detection of non-histaminergic itch stimuli 
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and the subsequent activation of itch-specific neural pathways. While several exogenous 
compounds trigger Mrgpr activation, endogenous ligands or modulators of MrgprA3 and 
MrgprC11 receptors have yet to be identified.  
Both serine and cysteine proteases have been implicated in triggering itch and 
inflammation in the skin. The plant cysteine protease mucunain, derived from the tropical bean 
plant commonly known as cowhage, and the human cysteine protease, cathepsin S (cat S), elicit 
itch in human volunteers(Reddy et al., 2008, 2010). We demonstrated previously that cat S, 
mucunain and other plant cysteine proteases including papain, bromelain and ficin are capable of 
activating PAR2 and PAR4(Reddy and Lerner, 2010; Reddy et al., 2010). It has been presumed 
that cysteine protease-evoked itch was induced via PAR2 activation. The possibility that 
activation of receptors other than PARs could be responsible for this sensation has not been 
investigated. MrgprC11 is activated by SLIGRL, a synthetic peptide generated based on the 
tethered sequence of the PAR2 N terminus following cleavage by serine proteases(Liu, 2011). 
This observation is surprising because Mrgprs are not members of the PAR family. MrgprC11 
does not have either arginine or lysine residues in its N-terminal extracellular domain. This 
receptor would neither be cleaved nor in theory activated, by serine proteases including trypsins 
and kallikreins. In contrast, the MrgprC11 receptor N terminus contains glycine and leucine 
residues, both cleavage targets for aspartyl and cysteine proteases(Rawlings et al., 2012).  
Here, we formally investigated whether select cysteine proteases are capable of cleaving 
and activating MrgprC11 receptors in vitro, and determined the significance of MrgprC11 
signalling in mediating cat S-induced scratching in vivo. The results demonstrate that cathepsin S 
provokes itching by cleavage of MrgprC11 at a specific site, resulting in activation of this 
receptor without generating either a tethered or diffusible ligand. Although cathepsin S can 
activate PAR2 receptors, such an activation is not necessary for itching provoked by this protease. 
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Hybrid receptors in which the N terminus of MrgprC11 was replaced with the N terminus from 
either the β2AR or MC1R were also activated by cathepsin S. These findings highlight the 
possibility that cysteine proteases may exert effects on other “non-PAR” GPCRs and further 
suggest that proteases are capable of modulating GPCRs by multiple mechanisms. 
 
Methods 
Reagents, peptides and antibodies  
Recombinant cat S was generated as previously described(Reddy et al., 2010) and diluted 
in 1x PBS, pH 7.4, 5mM EDTA, 5mM dithiothreitol and 5mM cysteine chloride. Papain (Sigma-
Aldrich) was diluted in 0.1x PBS, 50mM sodium acetate, pH 6.5, 5mM EDTA, 5mM 
dithiothreitol and 5mM cysteine chloride. Crystalline papain is more active and has a broader 
cleavage range than recombinant cat S. Different incubation times or concentrations were thus 
used as indicated. N-terminal peptides derived from the sequence of MrgprC11 were obtained 
from GenScript and diluted in PBS. The 28 amino-acid N-terminal peptide 
MDPTISSHDTESTPLNETGHPNCTPILT was made by Peptide 2.0 (Chantilly, VA). The 
cysteine protease inhibitor E-64 was obtained from Sigma-Aldrich. Similar results were obtained 
at either 5 or 10 mM of this compound. Anti-Gaussia luciferase, catalogue # E8023S from New 
England Biolabs was used at a dilution of 1:1,500. Anti-phospho-PKC (pan) (bII Ser660) 
catalogue #9371 from Cell Signaling Technology was used at a dilution of 1:1,000. Horseradish 
peroxidase (HRP)-labelled donkey anti-rabbit, catalogue # NB660–894, and anti-mouse 
antibodies, catalogue # NB7544, were from Thermo Fisher and used at 1:2,000 and 1:5,000, 
respectively. Molecular weight markers were Bioreagents EZ-run prestained rec protein ladder, 
cat # 3603500 from Thermo Fisher. All other reagents were purchased from Invitrogen, unless 




WT and PAR2 KO mice were obtained from Jackson Laboratories. Mrgpr cluster KO 
mice were generated by our lab as previously described(Liu, 2009). The mouse studies were 
performed at Johns Hopkins and approved by the IACUC at that institution.  
Cell culture  
HeLa cells were obtained from the ATCC and maintained in DMEM supplemented with 
fetal bovine serum, L-glutamine, penicillin and streptomycin (Fisher Biochemicals). Dissociated 
DRG neurons were prepared from WT, Mrgpr cluster KO, PAR2 KO and Pirt-GCaMP3 mice as 
reported previously(Liu, 2009). DRGs were collected from all spinal levels of 4-week-old mice, 
placed in cold medium and treated with enzyme solution at 37°C. Following titration and 
centrifugation, cells were suspended, plated on glass coverslips coated with poly-D-lysine and 
laminin, incubated at 37°C and used within 48 h.  
Cloning of WT MrgprC11 and generation of mutants  
The coding region of MrgprC11 was cloned by PCR from mouse genomic DNA using 
the forward and reverse primers: 50-GCGCTCGAGAGCATGGATCCAACCATCTCATC-30 
and 50-GCGAAGCTTTCAATATCTGCTTTCTGAAATCTC-30. C11 N-terminal mutants were 
made by site-specific mutagenesis procedures to change the listed residues to isoleucine or 
arginine at the P2 site. Leucine at P2 is the preferred site for cleaved by cathepsin S as in native 
MrgprC11, with isoleucine less so and arginine not at all.  
Preparation of G. luciferase–MrgprC11 fusion cDNAs  
G. luciferase complementary DNA (cDNA) was cloned, without its termination codon, 
into pcDNA3.1 as an XbaI–XhoI fragment. MrgprC11 cDNA was fused as an XhoI–HindIII unit 
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at the 30 terminus of the luciferase cDNA to obtain LucMrgprC11. Preparation of MrgprC11 with 
β2AR and MC1R amino termini. The MrgprC11 coding region without its N terminus from 
amino-acid 34 to its C terminus was cloned as an EcoRI–HindIII cDNA into pcDNA3.1 to obtain 
the vector pMrgprC11NR. The N termini of b2AR and MC1R from amino acids 1–34 and 1–37, 
respectively, were isolated as XhoI–EcoRI fragments by PCR, and cloned into pMrgprC11NR to 
generate the vectors pARC11 and pMC1RC11 for expression of the chimeric receptors β2AR–
MrgprC11 and MC1R–MrgprC11.  
Calcium imaging  
HeLa cells were grown to confluence, trypsinized and then transfected with the pcDNA 
vector carrying the G. luciferase–MrgprC11 fusion construct, MrgprC11 cDNA or salmon sperm 
DNA as a control using Lipofectamine 2000. Transfected cells were plated into 96-well glass-
bottom plates at 50,000 cells per well and maintained at 37°C in 5% humidified CO2 for 3 h after 
which time the medium was replaced. Twenty-four to 48 h after transfection, cells were incubated 
for 60 min at room temperature with 2 mM of Fura-2-acetoxymethyl ester (Fura-2) diluted in 
complete DMEM. Following Fura-2 loading, the medium was replaced with 90 ml of HEPES-
buffered saline (20mM HEPES, 115mM NaCl, 5.4mM KCl, 2mM CaCl2, 0.8mM MgCl2 and 
13.8mM glucose, pH 7.4) and cells were used immediately for calcium imaging. A luciferase–
receptor construct was used in all tranfections to establish consistency of transfection efficiency. 
Ratiometric calcium imaging was performed using a Zeiss Axiovert 200M microscope equipped 
with a flipping filter wheel and Axiovision software (version 4.6). Peptide and protease agonists, 
cat S or papain were added 15 s after initiating image acquisition and typically represented by 
down arrows in the figures. Images were acquired at time 0 and every 5 s thereafter for at least 90 
s. All images obtained during each acquisition period were analyzed. Each experiment was 
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performed at least three times, and ratiometric changes were measured in at least 20 cells per 
acquisition with responses of three representative cells.  
Primary DRGs cultured from WT, Mrgpr cluster KO and PAR2 KO mice were loaded 
with Fura-2 for 30 min at 37°C for ratiometric calcium imaging as described above following 
application of cat S and papain (5 and 20 mM, respectively). For experiments incorporating RNA 
interference, MrgprA3 and MrgprC11 on-target short interfering RNAs (siRNAs) were purchased 
from Thermo Scientific. MrgprA3 or MrgprC11 siRNA (0.175 nmol) were electroporated, 
respectively, into DRG neurons from Pirt-GCaMP3 mice that had been generated previously(Kim, 
2014; Liu, 2009).  
Electroporation of dissociated DRG neurons with Mrgpr-expression constructs was 
carried out using Mouse Neuron Nucleofector Kit (Amaxa Biosystems) following the 
manufacturer’s instructions. Electroporated neurons were plated and cultured as described above 
and used within 72 h. Green fluorescence from genetically encoded calcium GCaMP3 was 
detected via single-photon Ca2+ imaging with a 700 Zeiss confocal microscope, using the 488-nm 
line of a solid-state laser for excitation of Pirt-GCaMP3 and a 488-nm laser main dichroic beam 
splitter and a 505–555-nm variable secondary dichroic mirror to detect the emission of green 
fluorescence. 
Real-time quantitative PCR  
Total RNA was extracted from cultured DRGs 3 days after siRNA electroporation using 
an Rneasy micro kit (Qiagen). Purified RNA was quantified on a Nanodrop 2000 UV 
spectrophotometer (Thermal Scientific) at 260 nm and assessed for purity using the 260/280-nm 
ratio. DNA was reverse transcribed with the Superscript First Strand Synthesis System 
(Invitrogen). PCR amplifications were carried out with a Step One Plus real time PCR system 
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(Applied Biophysics). PCR conditions were 95°C for 3min and 50 cycles of 95°C for 30 s and 
60°C for 60 s.  
Primers as listed below: MrgprC11-F 50-AGCATCCA CAACCCCAGAAG-30; 
MrgprC11-R 50-TGGAGTGCAGTTGGGATGAC-30; MrgprA3-F 50-
ACACAAGCCAGCAAGCTACA-30; MrgprA3-R 50-ACTTCCAG GGATGGTTTCGT-30; 
Actin-F 50-CGTCGACAACGGCTCCGGCATG-30; Actin-R 50-
CCACCATCACACCCTGGTGCCTAGG-30  
All primers were intron spanning to avoid genomic DNA contamination. Melting curve 
analysis was applied to all final PCR products after the cycling protocol. Samples were run in 
triplicate, and threshold cycle (Ct) values from each reaction were averaged. Relative messenger 
RNA levels of MrgprA3 and MrgprC11 were calculated from threshold cycles and normalized to 
the actin level. Experiments were carried out three times with samples from different animals, and 
the Student’s t-test was used to determine significance.  
Concentration-effect measurements for cat S and papain.  
HeLa cells transfected with MrgprC11 cDNA were analysed using ratiometric imaging as 
described above with cat S and papain at concentrations from 1 nM to 10 mM. Each of the 
concentration-dependent readings was performed in triplicate. Maximum intensities at each of the 
dilutions were calculated and plotted against concentration using GraphPad Prism software. Error 
bars represent s.e.m. within an experiment, although these experiments were performed multiple 
times with similar results. Luciferase assay. MrgprC11 plasmid DNA (10 mg) or salmon sperm as 
control was transfected into HeLa cells as described above and plated into 10-cm dishes. Forty-
eight hours after transfection, the cells were washed with PBS, scraped and pelleted. Cells were 
suspended in a volume of 200 ml PBS and 100 ml were incubated with cat S (2 mM) or papain 
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(0.02 mM) in the presence or absence of the irreversible cysteine protease inhibitor E-64 for 10 
min at room temperature. Control cells were not treated with protease.  
Protease activity was quenched by adding 300 ml of complete DMEM, after which the 
cells were centrifuged and supernatants (50 ml) were assayed in triplicate for luminescence 
according to the instructions of the manufacturer (New England Biolabs). These experiments 
were performed multiple times with protease activity being quenched at many different time 
points so as to catch luminescence associated with papain, as this protease has the capacity to 
digest luciferase.  
Western blot analysis for luciferase  
HeLa cells transfected with the G. luciferase–MrgprC11 fusion construct were treated 
with cat S (2 mM) or papain (0.02 mM) for 10 min. Cells were pelleted and the supernatant was 
added directly to loading buffer to quench enzymatic activity, run on NuPAGE Novex Bis-Tris 
mini gels and transferred to nitrocellulose membranes. Membranes were probed with a primary 
rabbit anti-G. luciferase antibody followed by HRP-labelled donkey anti-rabbit antibody for 
reaction with the ECL substrate to identify protein bands. The results presented are representative 
of one of four experiments.  
Western blot analysis for p-PKC (Ser660) 
HeLa cells were transfected with MrgprC11 plasmid DNA as described above and plated 
onto three 10-cm dishes. Non-transfected HeLa cells were also plated into three other 10-cm 
dishes. Forty-eight hours after transfection, cells were washed with PBS and then treated with 
papain or cat S at 0.02 and 2 mM, respectively, for 10 min. A subset of HeLa cells that were not 
transfected was treated with papain, cat S or PBS alone as controls. Cells were harvested by 
scraping, pelleted and lysed by repetitive freeze–thaw cycles. Cell lysates were centrifuged at 4°C 
58 
	  
for 15 min. Supernatants were collected and protein concentrations were determined by the 
Bradford assay. Equal amounts of cell lysates were loaded onto NuPAGE Novex Bis-Tris mini 
gels, electrophoresed and transferred to nitrocellulose membranes. Membranes were probed with 
rabbit anti-phospho-PKC (bII Ser660) followed by incubation with HRP-labelled donkey anti-
rabbit antibody for reaction with the ECL substrate to identify protein bands on the membrane. 
The blot was re-probed with mouse anti-actin antibody to identify the control actin band (42 kDa). 
HRP-labelled anti-mouse antibody was used as a secondary antibody for the ECL substrate. This 
experiment was repeated three times and error bars represent ±s.e.m. between the individual 
bands between three separate experiments, with relative intensities quantified using ImageJ.  
Behavioral studies  
All mice used for behavioral studies were 2- to 3-month-old males (20–30 g) and were 
backcrossed to C57BL/6 mice for at least 10 generations. Mice were habituated for 30 min per 
day for 3 days prior and then at least 15 min on the day of the study. Intradermal injections of 10 
µl cat S 80 mM were delivered to the cheek(Shimada and LaMotte, 2008). Scratching behavior 
was observed for 30 min. A scratching bout was defined as continuous scratching movements 
with hind paws directed at the site of injection. Scratching behavior was quantified by recording 
the number of scratching bouts at 5-min intervals over a 30-min observation period. 
Experimenters were blind to genotype. Data are presented as mean±s.e.m. n represents the 
number of mice analyzed or times the experiments were performed. The distribution of the 
variables in each experimental group was approximately normal. Statistical comparisons were 
conducted by two-tailed, unpaired Student’s t-test. Differences were considered to be statistically 
significant for P<0.05. Representative data are from experiments that were replicated biologically 




Cysteine proteases cleave the N terminus of MrgprC11 
MrgprC11 plays a critical role in mediating pruriception from the periphery. These 
receptors are known to bind several well-recognized pruritogens, including peptides resulting 
from the cleavage of PARs. Whether or not proteases have any direct effect on Mrgpr receptors 
was not known. To address this possibility, we asked whether cysteine proteases could cleave the 
extracellular N-terminal portion of MrgprC11. HeLa cells were transfected with a construct 
encoding MrgprC11 tagged with Gaussia luciferase at its N terminus and then treated with cat S 
or papain. Receptor cleavage was assessed by measuring levels of luminescence in the 
supernatants (Figure 3.1). Both papain and cat S induced cleavage of the MrgprC11 N terminus 
as determined by luminescence (Figure 3.1A). Incubation with E-64, an irreversible cysteine 
protease inhibitor, blocked protease-mediated cleavage of the N termini. In separate studies, 
tagged MrgprC11-tranfected cells were treated with cysteine proteases. Western blots of 
supernatants probed with an anti-G. luciferaseantibody revealed a dense band at ~20  kDa in cells 
treated with cat S or papain, consistent with the mass expected of an N-terminal peptide tagged 
with G. luciferase (Figure 3.1B). As expected, no bands were identified in controls in which 
transfected cells were not treated with protease. These results reveal that cysteine proteases cleave 




Figure 3.1 Cysteine proteases cleave near the N terminus of MrgprC11 
(A) Luminescence was measured after treating LucMrgprC11-transfected HeLa cells with cat S 
(2  µM) and papain (2  µM) in the presence or absence of E-64 (5  µM). Baseline luminescence has 
been subtracted. The data are presented as mean±s.e.m. **P<0.001, ***P<0.0005; two-tailed 
unpaired t-test from a representative experiment that was performed three times. (B) Western blot 
of LucMrgprC11 N-terminal cleavage products following treatment of transfected HeLa cells 
with control buffer without proteases (lane 1), papain, 0.02  µM (lane 2) and cat S, 2  µM (lane 3). 
The lesser amount of luminescence from papain as compared with cat S in a is likely a result of 
higher enzyme activity and a broader range of cleavage sites for papain. Similarly, for b, a lesser 
concentration of papain as compared with cat S was used for incubation times to be the same for 
detection of luciferase. See the Methods and Discussion sections for additional comments. 
Results from Dr. Ethan Lerner’s group. 
 
Cysteine proteases activate MrgprC11 in vitro 
We next asked whether cysteine proteases were capable of activating MrgprC11. This 
receptor signals via Gq, resulting in phospholipase C activation and, via second messenger 
61 
	  
recruitment, increased intracellular free Ca2+ and protein kinase C activation(Wilson et al., 2011). To 
assess receptor activation, we performed calcium imaging using the ratiometric calcium indicator 
Fura-2 in HeLa cells transfected with MrgprC11 following treatment with cat S or papain. Each 
protease elicited calcium responses (Figure 3.2A), activating MrgprC11 in a concentration-
dependent manner with an effector concentration for half-maximum response of ~140  nM (Figure 
3.2B). Calcium responses were ablated when cells were treated with the protease inhibitor E-64 
(Figure 3.2A). In contrast to the robust responses induced by cysteine proteases, we confirmed 
that trypsin, a serine protease, does not activate MrgprC11(Liu, 2011). Western blotting revealed 
PKC phosphorylation at serine 660 (Ser660) following treatment with cat S and papain (Figure 
3.2C). Quantification of the bands revealed an approximate 4.6-fold increase in p-PKC associated 
with protease activation relative to controls. 
We next assessed whether cysteine proteases activate endogenously expressed Mrgpr 
receptors on dorsal route ganglion (DRG) neurons. Both cat S and papain treatment evoked 
calcium signals in DRGs from WT mice (Figure 3.2D). Fewer DRG neurons harvested from mice 
in which a cluster of Mrgpr genes, including MrgprC11, have been deleted (Mrgpr cluster 
Δ−/−mice), responded to cat S (Figure 3.2D). The lack of response of these neurons to papain is 
likely due to receptor inactivation by papain under the conditions used. Because cat S is known to 
activate PAR2 when it is expressed in heterologous cell lines(Reddy et al., 2010), we evaluated 
the effect of cat S on DRGs harvested fromPAR2−/− mice. Of note, calcium responses to cat S 
remained intact in the absence of PAR2 receptors (Figure 3.2D). These data support a role for 
protease-induced MrgprC11 activation in DRGs and, importantly, identify cat S as a potential 
endogenous and relevant ‘ligand’ for this receptor. The average diameter of responsive neurons 




Figure 3.2 Cysteine proteases activate MrgprC11 in heterologous cells and DRG neurons 
and induce PKC phosphorylation 
(A) Single-cell calcium imaging in HeLa cells transfected with MrgprC11 cDNA following 
treatment with cat S (2  µM, solid line), papain (2  µM, dashed line), cat S+E-64 (10  µM; dotted 
line), papain+E-64 (10  µM; dash-dotted line) and trypsin (10  nM) dash-double-dotted line. The 
concentration of trypsin is typical of that used in studies of PARs. Higher concentrations of 
trypsin, including those in the micromolar range, did not activate MrgprC11. (B) Concentration–
effect curves for protease agonists cat S (squares) and papain (circles) on MrgprC11. Error bars 
represent ± s.e.m. from three sets of experiments. (C) Phosphorylation of serine 660 as a measure 
of second messenger is revealed by western blot. HeLa cells were transfected with MrgprC11 
63 
	  
(lanes 1–3), or non-transfected HeLa cells (lanes 4–6) were treated with buffer alone (lanes 1 and 
4), cat S (lanes 2 and 5) or papain (lanes 3 and 6). Results from Dr. Ethan Lerner’s group. (D) 
The percentage of DRG neurons activated by cat S (5  µM) was significantly reduced in Mrgpr 
cluster knockout mice as compared with WT DRG neurons (n=3, P<0.001). The percentage of 
DRG neurons activated by papain (20  µM) was reduced to zero in Mrgpr cluster knockout mice 
as compared with WT mice (n=3, ***P<0.001; two-tailed unpaired t-test). The percentage of 
DRG neurons activated by cat S (5  µM) is not significantly different between WT 
and PAR2−/− mice (n=3, P=0.74). (E) Representative calcium traces of cat S (5  µM) in DRG 
neurons from WT, Mrgpr cluster Δ−/− and PAR2−/− mice. Each trace represents responses from a 
single neuron. Arrows indicate application of cat S. 
 
RNA interference (RNAi) knockdown of MrgC11 and closely related MrgprA3 was 
performed in DRG neurons (Figure 3.3). Messenger RNA levels of both genes were significantly 
lower as confirmed by real-time PCR (Figure 3.3D). Knockdown of MrgprC11 only abolished the 
calcium response to the MrgprC11 ligand cat S but not the MrgprA3 ligand chloroquine. In 
contrast, knockdown of MrgprA3 only affected the response to chloroquine but not the response 
to cat S, showing effectiveness and specificity of RNAi. Note that transient knockdown of 
MrgprC11 totally abolished the cat S-induced response, while knockdown of MrgprA3 only 
reduced the response to chloroquine. This result is consistent with the stronger knockdown effect 
of MrgprC11. The observation that transient knockdown eliminates the calcium response to cat S 
suggests that the remaining calcium response in Mrgpr cluster knockout (KO) mice may be due to 
an otherwise unspecified compensation mechanism in the permanent KO. In summary, these data 
support a role for protease-induced MrgprC11 activation in DRGs and, importantly, identify cat S 




Figure 3.3 Acute knockdown of MrgprC11 abolishes DRG response to cathepsin S 
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(A) MrgprA3 knockdown DRG neurons responded normally to cat S (5  µM), while MrgprC11 
knockdown DRG neurons showed no response (n=4, P<0.05). In contrast, chloroquine (CQ) 
(2  mM) induces calcium responses in ~4% of MrgprC11 knockdown DRGs, while knockdown of 
MrgprA3 markedly reduced the response to CQ (n=4, P<0.05). (B) Representative calcium traces 
from MrgprA3 knockdown DRG neurons in response to cat S and chloroquine. (C) 
Representative calcium traces from MrgprC11 knockdown DRG neurons in response to cat S and 
chloroquine. Each trace represents responses from a single neuron. Arrows indicate application of 
cat S. (D) Relative messenger RNA (mRNA) level of MrgprA3 and MrgprC11 in the respective 
knockdown DRGs as determined by real-time PCR. The data are presented as 
mean±s.e.m. *P<0.05, **P<0.01; ***P<0.001; two-tailed unpaired t-test. 
 
Cathepsin S induces scratching via MrgprC11 
Cat S has been shown previously to cleave and activate PAR2 in vitro(Reddy et al., 2010). 
It has been assumed, but never demonstrated clearly, that PAR2 activation is the mechanism by 
which cat S evokes scratching in mice and itch in humans. However, in light of our in 
vitro findings that cat S-induced calcium signalling in DRGs requires MrgprC11 but not PAR2, 
we sought to determine the relative importance of these two receptors, if any, to cat S-induced 
scratching in vivo. We thus compared behavioural scratching responses with intradermal injection 
of cat S using the mouse cheek model in WT, Mrgpr cluster Δ−/− mice and PAR2−/− mice. Pain 
and itch can be readily distinguished using the cheek injection model(Shimada and LaMotte, 
2008). We only observed itch associated hind-paw scratching, but not pain-related fore-paw 
wiping. Injection of cat S elicited robust scratching behaviour in WT mice, but was markedly 
reduced in Mrgpr cluster Δ−/− mice (Figure 3.4A). Perhaps surprisingly, scratching 
in PAR2−/− mice was as robust as in WT littermates (Figure 3.4B). These experiments underline 




Figure 3.4 Cathepsin S-induced scratching is reduced in Mrgpr cluster Δ−/− mice 
(A) Scratching behaviour of WT and Mrgpr cluster Δ−/− mice in response to cat S, n=11, P=0.04, 
and compared with baseline saline vehicle alone (n=9). (B) Scratching behaviour of WT 
and PAR2−/− mice in response to cat S was not significantly different, n=7, P value 0.32. The data 
are presented as mean±s.e.m.*P<0.05; two-tailed unpaired t-test. 
 
MrgprC11 N-terminal cleavage sites 
We next sought to determine whether cleavage of the extracellular N-terminal domain of 
MrgprC11 is necessary for protease-induced receptor activation, and if so, to identify the relevant 
cleavage sites. As per the MEROPS database, preferred amino acids for cleavage by cat S and 
papain include leucine at P2 and glycine, serine and aspartic acid at P1. Using site-specific 
mutagenesis, we generated a series of single-, double- and triple-substitution mutants near the 
MrgprC11 N terminus (Table 3.1). Calcium imaging of HeLa cells transfected with these mutant 
receptors revealed that leucine13 was a critical residue for cat S-mediated cleavage and activation. 
Papain required both aspartic acid9 and leucine13 for receptor cleavage and activation (Table 3.1). 
None of the other candidate residues including glycine14, serine6, 7, 15 and leucine16 were required 
for receptor activation by either protease. 
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Table 3.1 Responses of wild-type MrgprC11 or MrgprC11 N-terminal mutants following 
treatment with cat S, papain or SLIGRL as determined by calcium imaging 
MrgprC11 N terminus: M1DP TIS SHD TES TPL NET GHP NCT PIL TLS FLV31 
MrgprC11 WT and mutant receptors Cat S, 2  µM Papain, 2  µM SLIGRL, 10  µM 
C11 WT + + + 
C11-1 (L15I) − + + 
C11-2 (G19I) + + + 
C11-3 (L15I, G19I) − + + 
C11-4 (L15I, G19I, L27I) − + + 
C11-5 (S30I) + + + 
C11-6 (D9I) + + + 
C11-7 (D9I, L15I) − − + 
C11-8 (S6I, S7I) + + + 
C11-9 (L15R) − + + 
Cat S, cathepsin S; Mrgprs, Mas-related G-protein-coupled receptors; WT, wild type. ‘+’ 
indicates that the indicated receptor was activated. The indicated amino acids were each mutated 
to isoleucine, except for mutant MrgprC11-9 in which L15 was changed to R. Note that SLIGRL 
activated all of the receptors. Results from Dr. Ethan Lerner’s group. 
 
To determine the specific protease cleavage sites, a peptide corresponding to the 28N-
terminal residues of MrgprC11 was synthesized, MDPTISSHD9TESTPL13 NETGHPNCTPILT. 
The aspartic and leucine residues required for papain and cat S activity are indicated. This peptide 
was incubated with cat S or papain and then subjected to mass spectrometry (MS)/MS peptide 
sequence analysis, as described in Table 3.2, as we have done previously with cat S and 
PAR2(Elmariah et al., 2014). Cat S cleavage occurred between N16 and E17 with L15at the P2 
position, MDPTISSHD9TESTPL15N↓ETGHPNCTPILT, consistent with the site-directed 
mutagenesis approach above. Substituting arginine for leucine13 completely eliminated the 
response to cat S (Table 3.1; Figure 3.5B). Papain preferred L15 at the P2 position and cleavage 
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between N16 and E17 but no additional specificity was apparent, and cleavage otherwise occurred 
at multiple sites. 
 
Table 3.2 MS/MS data from incubation of the mouse MrgprC11 N-terminal peptide 
Sequence 
Number Sequence Count 
Sequence 
Number Sequence Count 
1 DPTISSBDTESTPLN* 4 42 
MDPTISSHDTESTPLNETGHPNCT
PILT 2 
2 DPTISSBDTESTPLNETG 1 43 PLNETGHPN 4 
3 ESTPLNETGHPN 4 44 PLNETGHPNC 2 
4 ESTPLNETGHPNC 4 45 PLNETGHPNCTPILT 2 
5 ESTPLNETGHPNCTPLLT 3 46 PLNETGHPNCTPILTLS 1 
6 ETGHPNCTPI** 3 47 PTISSHDTE 5 
7 ETGHPNCTPIL** 2 48 PTISSHDTES 3 
8 ETGHPNCTPILT** 16 49 PTISSHDTESTPLN* 4 
9 ETGHPNCTPILTL** 3 50 PTISSHDTESTPLNE 2 
10 GHTNCTTILI 2 51 PTISSHDTESTPLNETG 5 
11 HDTESTPLN* 6 52 PTISSHDTESTPLNETGHPN 5 
12 HDTESTPLNE 5 53 PTISSHDTESTPLNETGHPNC 1 
13 HDTESTPLNETG 8 54 
PTISSHDTESTPLNETGHPNCTPIL
T 1 
14 HDTESTPLNETGHPN 6 55 SHDTESTPLN* 4 
15 HDTESTPLNETGHPNC 5 56 SHDTESTPLNE 2 
16 HDTESTPLNETGHPNCTPILT 4 57 SHDTESTPLNETG 2 
17 HPNCTPIL 3 58 SHDTESTPLNETGHPN 6 
18 HPNCTPILT 5 59 SHDTESTPLNETGHPNC 3 
19 HPNCTPILTL 3 60 SHDTESTPLNETGHPNCTPILT 4 
20 HPNCTPILTLS 5 61 SSHDTESTPLN* 6 
21 ISSHDILS 1 62 SSHDTESTPLNE 2 
22 ISSHDILSTPLN* 2 63 SSHDTESTPLNETGHPN 4 
23 ISSHDILSTPLNE 3 64 SSHDTESTPLNETGHPNC 5 
24 ISSHDILSTPLNETG 1 65 SSHDTESTPLNETGHPNCTPIL 1 
25 ISSHDILSTPLNETGRDN 3 66 SSHDTESTPLNETGHPNCTPILT 8 
26 M*DPTISSHDTE 1 67 STPLNETGHPN 2 
27 M*DPTISSHDTES 3 68 STPLNETGHPNC 2 
28 M*DPTISSHDTESTPLN 1 69 STPLNETGHPNCTPILT 4 
29 M*DPTISSHDTESTPLNE 3 70 TESTPLN* 2 
30 M*DPTISSHDTESTPLNETG 1 71 TESTPLNE 2 
31 M*DPTISSHDTESTPLNETGHPN 1 72 TESTPLNETG 2 
32 MDPTISSH 3 73 TESTPLNETGHPN 1 
33 MDPTISSHD 1 74 TESTPLNETGHPNC 1 
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34 MDPTISSHDT 1 75 TESTPLNETGHPNCTPILT 2 
35 MDPTISSHDTE 6 76 TGHPNCTPILT 4 
36 MDPTISSHDTES 2 77 TGHPNCTPILTL 2 
37 MDPTISSHDTESTPLN 7 78 TGHPNCTPILTLS 3 
38 MDPTISSHDTESTPLNE 4 79 TPLNETGHPN 5 
39 MDPTISSHDTESTPLNETG 5 80 TPLNETGHPNC 3 
40 MDPTISSHDTESTPLNETGHPN 5 81 TPLNETGHPNCTPILT 4 
41 MDPTISSHDTESTPLNETGHPNC 9 
   
 
 
MDPTISSHDTESTPLNETGHPNCTPILT with papain. The peptides are listed in order 
beginning with the highest total ion count. Other than cleavage by papain associated with L15 at 
the P2 position, no cleavage preference was identified. (Sequence) represents the amino acid 
sequence of the peptides identified by MS/MS following incubation with papain. (count) 
represents the number of times this sequence was identified. * indicates the peptides in which 
incubation with papain results in a C-terminus with L15 at the P2 position. ** indicates the 
peptides in which incubation with papain results in E17 at the N-terminus, consistent with 




Figure 3.5 N-terminal peptides do not activate MrgprC11 and cat S requires L15 for activity 
(A) A series of eight MrgprC11 N-terminal peptides was generated based on possible protease 
cleavage sites. (B) Calcium imaging of HeLa cells transfected with MrgprC11 following 
treatment with a representative MrgprC11 N-terminal peptide, C11-1 100  µM, the hexapeptide 
tethered ligand ETGHPN at the cat S cleavage site. (C) Cat S does not activate the MrgprC11 in 
which L15 has been changed to R. Note that SLIGRL activates the native and mutant receptors. 
Arrows represent addition of test reagent. Results from Dr. Ethan Lerner’s group. 
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MrgprC11 is not activated by tethered or diffusible ligands 
As conventional PARs are activated by tethered ligands generated following protease-
mediated cleavage of their N-terminal domains, we sought to determine whether such peptides 
could activate MrgprC11. We generated a series of eight peptides (Figure 3.5A) ranging from 6 to 
15 amino acids based on predicted cleavage sites near the MrgprC11 N terminus. These included 
the tethered hexapeptide ETGHPN that begins at the cat S cleavage site, and the diffusible 
peptide MDPTISSHDTESTPLN that begins at the N terminus of MrgprC11 and ends at the cat S 
cleavage site. In contrast to PAR2 N-terminal peptides, synthetic MrgprC11 N-terminal peptides 
failed to elicit calcium responses in MrgprC11-expressing cells (Figure 3.5B). These data reveal 
that in contrast to the activation of PARs, Mrgpr activation does not occur via generation of either 
a tethered or diffusible ligand. 
Proteases activate β2AR and MC1R–MrgprC11 hybrid receptors 
We have shown thus far that protease-mediated cleavage of MrgprC11 causes receptor 
activation without the formation of either a tethered or diffusible ligand. Another possible 
explanation of the ability of cysteine proteases to activate Mrgprs is that proteolysis of the 
extracellular domain results in a direct conformational change of the intracellular portion of the 
receptor that allows G-coupled signalling to occur. If this is the case, a mutant MrgprC11 in 
which the native N terminus has been substituted with the N terminus of an unrelated GPCR that 
can also be cleaved by cysteine proteases might be activated by proteolysis. To evaluate this 
possibility, we substituted the N terminus of MrgprC11 with either that of the β2-adrenergic 
receptor (β2AR) or the melanocortin-1 receptor (MC1R). These receptors are class A GPCRs, 
such as Mrgprs, but they couple primarily to Gs. We selected β2AR and MC1R because of the 
deep knowledge surrounding their structure and function. Each of these receptors contains 
residues that can be cleaved by cysteine proteases. However, biogenic amines and melanocortins, 
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respectively, not proteases, are their conventional ligands. As predicted, both cat S and papain 
treatment of HeLa cells transfected with hybrid receptors β2AR–MrgprC11 or MC1R–MrgprC11 
resulted in robust calcium signalling. As controls, protease treatment did not result in calcium 
mobilization in HeLa cells expressing native β2AR or MC1R (Figure 3.6). Taken together with 
the site-specific mutagenesis results, these findings argue that cat S- or papain-mediated cleavage 
of specific N-terminal residues directly triggers conformational changes in the transmembrane 
and/or intracellular domains of the MrgprC11 receptor that lead to downstream signalling. 
 
 
Figure 3.6 Cathepsin S and papain activate MrgprC11 downstream signalling in N-terminal 
exchange receptors 
(A) Cat S and papain activate β2AR–MrgprC11 but not the WT AR as determined by calcium 
imaging. (B) Cat S and papain activate MC1R–MrgprC11 but not WT MC1R as determined by 




Effect of cysteine proteases on other Mrgprs 
To determine whether cysteine protease-mediated receptor activation was specific to 
MrgprC11, we examined whether cat S and papain were capable of triggering calcium 
mobilization in HeLa cells transfected with other members of the Mrgpr family, including human 
MRGPRX1–4 as well as mouse MrgprA3, which mediates chloroquine-induced itch. We found 
that in addition to activating human PAR2 and mouse MrgprC11, cat S activated human 
MRGPRX2 (Table 3.3). Cat S failed to activate other human MRGPRs and mouse MrgprA3 
(Table 3.3). In contrast, papain activated human MRGPRX1, but had no effect on the other 
human MRGPRs (Table 3.3). As expected, trypsin failed to activate these Mrgprs (Figure 
3.2A; Table 3.3). These results demonstrate that cysteine proteases activate only select Mrgprs, 
and that cat S, in particular, activates mouse and human Mrgprs that have been implicated in itch 
transmission. 
Table 3.3 Responses of PAR2 and Mrgprs following treatment with cat S, papain and 
trypsin as determined by calcium imaging 
GPCR Cat S, 2  µM Papain, 2  µM Trypsin, 10  nM 
hPAR2 + + + 
hMRGPRX1 − + − 
hMRGPRX2 + − − 
hMRGPRX3 − − − 
hMRGPRX4 − − − 
mMrgprC11 + + − 
mMrgprA3 − − − 
Cat S, cathepsin S; Mrgprs, Mas-related G-protein-coupled receptors; PAR2, protease-activated receptor-2. 






Endogenous and exogenous proteases have long been implicated in the pathogenesis of 
many inflammatory diseases, including skin diseases(Deschamps, 2011; Reddy and Lerner, 2010; 
Reddy et al., 2010; Schonefuss, 2010).Our previous work showed that endogenous cat S and 
other proteases trigger histamine-independent itch(Reddy and Lerner, 2010; Reddy et al., 2008, 
2010). Transgenic mice in which cat S is overexpressed spontaneously develop an intensely 
pruritic, eczematous disorder resembling atopic dermatitis(Kim et al., 2012). In addition, cat S 
levels are selectively upregulated in psoriatic keratinocytes(Schonefuss, 2010), a condition also 
associated with considerable itch(Globe et al., 2009; Gupta et al., 2008; Prignano et al., 2009). 
Intradermal injection of cat S elicits acute itch in human subjects as well as scratching in 
mice(Kim et al., 2012; Reddy and Lerner, 2010). Until now, the exact mechanism by which 
cysteine proteases induce itch remained elusive and was presumed to require activation of the 
PAR2 receptor via generation of KVDGTS, a tethered ligand distinct from SLIGRL(Elmariah et 
al., 2014). We demonstrate for the first time that the cysteine proteases cat S and papain directly 
activate MrgprC11 to evoke histamine-independent scratching behavior. The activation kinetics 
of MrgprC11 by papain were prolonged relative to those of cat S. The mechanism for this 
prolonged activation is not clear but may result from a balance of receptor activation/inactivation, 
calcium-induced release from intracellular stores or perhaps endosomal receptor signalling 
associated with papain(Tsvetanova et al., 2015; Vilardaga et al., 2014). 
Consistent with protease activation of MrgprC11, scratching responses elicited by the 
intradermal injection of cat S were significantly reduced in Mrgpr cluster Δ−/− mice, but remained 
intact in PAR2−/− mice. In vitro correlates of these in vivo observations were demonstrated as the 
capacity of cat S to activate DRG neurons from Mrgpr cluster Δ−/− mice was markedly 
diminished while not significantly diminished in PAR2−/− DRG neurons. RNAi knockdown of 
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MrgprC11 specifically abolished the response of DRG neurons to cat S. In contrast, knockdown 
of MrgprA3 did not diminish the response of DRG neurons to cat S. It is not clear why the 
decrease in scratching responses in Mrgpr cluster Δ−/− mice, while significant, was not as 
substantial as the decrease in Ca2+ signals in DRG neurons from these mice. One potential 
explanation is that cat S activates PAR2 on keratinocytes, resulting in the release of thymic 
stromal lymphopoietin, a skin-derived cytokine that has been shown to induce itch via neuronal 
receptors for this molecule(Wilson et al., 2013). In addition, while PAR2 does not appear to have 
a direct role in cat S-evoked itch in WT mice, a non-native role may be unmasked in the absence 
of MrgprC11. Our data also identify the cysteine protease cat S as a functional endogenous ligand 
for Mrgprs, currently considered as orphan receptors. Whether other endogenous cysteine 
proteases activate Mrgprs awaits future investigations. 
Conventional PARs are GPCRs that are uniquely activated by proteolysis. In this 
scenario, proteases bind and specifically cleave residues in the N-terminal domain of the receptor 
to unmask a ‘tethered’ ligand that subsequently interacts with another portion of the receptor to 
trigger intracellular signalling. Similarly, PARs can be activated by synthetic hexapeptides that 
mimic the first six amino acids of the unmasked N terminus. The data presented here are the first 
to demonstrate that GPCRs other than PARs can be activated by proteolysis, as cysteine proteases 
activate MrgprC11. Site-specific mutagenesis revealed that cat S requires L15 and papain requires 
D9 and L15 for cleavage, while data from MS/MS demonstrated that cleavage occurs between 
residues N16 and E17. In contrast to PARs, tethered ligands do not appear to play a role in Mrgpr 
activation, and synthetic Mrgpr N-terminal peptides have no apparent functional activity. These 
data highlight the possibility that cysteine proteases may exert effects on other ‘non-PAR’ 




Classically, GPCRs are thought to become activated when ligands bind in a pocket 
formed by the transmembrane helices thereby triggering exposure of cytoplasmic domains 
required for coupling to heterotrimeric G-protein subunits(Ji et al., 1998). PARs, on the other 
hand, become activated when proteolysis allows for tethered ligands to interact with residues in 
the second extracellular loop, subsequently resulting in conformational changes in the 
transmembrane helices(Elmariah et al., 2014; Vu et al., 1991). While the exact mechanism by 
which proteolysis triggers activation of MrgprC11 remains unknown, we suggest that the N-
terminal domain interacts with the extracellular loops of the receptor to lock it in an inactive state. 
Cleavage of the N terminus by cysteine proteases may release this lock, shifting transmembrane 
and cytoplasmic domains as suggested with traditional PARs. Our observations that calcium 
signalling was evoked by cathepsin-induced proteolysis of the β2AR and MC1R N-terminal 
exchange mutants are consistent with this hypothesis. The mechanism underlying this observation 
deserves further study. 
It is interesting that although N-terminal MrgprC11 peptides did not activate Mrgpr 
signaling, SLIGRL, a PAR2 N-terminal peptide, is capable of inducing itch via activation of 
MrgprC11(Liu, 2011), at least at micromolar concentrations. Whether this effect occurs naturally 
is not clear. The concept that N-terminal peptides released into the extracellular milieu following 
PAR cleavage may exert a biologic effect independent of PARs has been reported. PAR1 
cleavage by thrombin generates an N-terminal peptide known as parstatin, which is capable of 
inhibiting vascular endothelial cell growth factor- and fibroblast growth factor-induced 
angiogenesis in vitro and in vivo. It also plays a role in modulating platelet function(Furman, 
2000; Zania, 2009). Whether protease-mediated cross-signalling between PAR2 and MrgprC11 
serves a relevant role in coupling itch and inflammation in vivo is not known. 
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Cysteine proteases, in particular cysteine cathepsins, are widely expressed in mammalian 
tissues and have been implicated in the pathophysiology of a diverse array of inflammatory, 
autoimmune and allergic diseases, as well as in neuropathic pain(Cattaruzza, 2011; Clark, 2007; 
Gupta et al., 2008; Inaoka, 1995; Mohamed and Sloane, 2006). Recent work in murine colitis 
models demonstrates that macrophage- and microglial cell-derived cat S induces colonic 
inflammation and pain by activating PAR2 on different cell types, linking increased paracellular 
permeability in colonocytes with nociceptive hyper-excitability and neurogenic inflammation in 
primary spinal afferent neurons(Cattaruzza, 2011; Jacob, 2005; Steinhoff et al., 2000; Zhao, 
2014). We suggest that cat S may similarly act as a key regulator linking itch and inflammation in 
the skin. Our work reveals a novel mechanism by which cat S accomplishes its diverse effects: 
activation of MrgprC11. 
Increased cat S expression has been reported in several common inflammatory skin 
conditions, including atopic dermatitis, psoriasis and seborrhoeic dermatitis(Kim et al., 2012; 
Schonefuss, 2010; Viode, 2014). Under these conditions, cat S may simultaneously contribute to 
itch and propagate inflammation via different but related mechanisms. First, as we demonstrated 
here, cat S induces itch directly by activating MrgprC11. Second, cat S-mediated activation of 
PAR2 may induce itch if PAR2 N-terminal peptides bind to MrgprC11 on primary sensory nerves. 
In addition, PAR2 activation in keratinocytes may trigger the release of thymic stromal 
lymphopoietin, which in turn activates cutaneous sensory neurons that express transient receptor 
potential ankyrin channel A1 (TRPA1), leading to itch stimulation and neurogenic 
inflammation(Wilson, 2013). Recognizing that proteases can recruit multiple distinct pathways to 
induce itch and inflammation may help drive the development of more effective therapeutic 
strategies to treat inflammatory diseases, shifting the focus from blocking individual downstream 
78 
	  
receptors to inhibiting protease–receptor complexes. This chapter is modified from previous 
publication(Reddy et al., 2015). 
 
CHAPTER 4: CONCLUSION AND FUTURE DIRECTIONS 
This thesis focuses on the central and peripheral mechanisms of pain and itch. We’ve 
identified a small subset of spinal interneurons receiving direct synaptic input from both pain and 
itch primary sensory neurons. Contrary to the current pain and itch coding theories, specific 
activation of these neurons intensity dependently generated robust pain and itch responses 
simultaneously. Such intensity dependent coding serves as a good example of currently 
overlooked non-monotonic coding in spinal cord circuitries. Accordingly, I proposed a “leaky 
gate” model, in which these neurons transmit both itch signals and weak pain signals (ensuring 
pain sensitivity) through the “gate”, but recruit endogenous opioid systems to close the “gate” 
upon strong painful stimuli to prevent overwhelming pain. This “leaky gate” functions as a brake 
for pain pathway to prevent intense stimuli from generating debilitating pain sensation, moreover, 
the advantage of a “leaky” gate lies in that pain sensitivity is preserved by the high triggering 
threshold of this “brake”. Consistent with our model, loss of these Grp+ neurons increased pain 
responses while itch was decreased. This model provides a refined theory of pain and itch coding 
in spinal cord and better explains observations in human psychophysical studies.  
The gate control theory of pain has yielded influential mechanistic understandings of pain 
circuitries over the years and provided spinal cord stimulation as an effective method of pain 
relief. Further research on this leaky gate model would likely lead to more detailed knowledge of 
complex pain and itch related spinal circuitries. Since the gate control system demonstrates 
maladaptive changes in chronic pain conditions, further studies of leaky gate model in 
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pathological conditions, such as chronic pain and chronic itch, would be a good start point. In 
addition, the residual itch responses and the increased pain behavior after the loss of Grp+ 
neurons indicates the existence of parallel pain and itch pathways. Grp cre line as well as the 
MrgprA3 cre line would serve as ideal tools to map parallel circuitries and determine whether 
candidate subsets such as those labeled by GRPR and NK1 receive direct synaptic input from 
Grp+ and MrgprA3+ neurons. Last but not least, the input-output relationship of Grp+ neurons was 
inferred by ex vivo recordings in combination with behavioral analysis. Direct examination of 
such relationship under physiological conditions, potentially via in vivo calcium imaging of 
spinal cord, could further consolidate findings presented in this thesis. 
In collaboration with Dr. Ethan Lerner’s group from Massachusetts General Hospital, we 
also discovered that cysteine proteases, including cathepsin S, cleave and activate G protein 
coupled receptors, MrgprC11. This is the first GPCR outside PAR family to be activated by 
protease cleavage. Moreover, in contrary to previous hypothesis that PAR2 mediate protease 
induced itch, cysteine proteases activate dorsal root ganglion neurons and trigger scratching in 
MrgprC11 dependent way. Interestingly, the activation of MrgprC11 involves a novel mechanism 
other than the generation of tethered ligand as in the case of PARs or diffusible ligands. Further 
study of this novel activation mechanism could expand our knowledge about GPCR signaling and 
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